Histopathology Flashcards

(453 cards)

1
Q

Neutrophils

A

associated with acute inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lymphocytes and plasma cells

A

associated with chronic inflammation and also lymphomas (sheaths of lymphocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Eosinophils

A

associated with allergic reactions (and drug-induced), parasitic infections, and tumours (eg. Hodgkin’s lymphoma eosinophils as a reaction to the cancer, they’re not the cancer cells themselves)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Eosinophilic oesophagitis

A

feline contractions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mast cells

A

characteristically large granules containing lots of inflammatory mediators
allergic reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Macrophages

A

lots of cytoplasm, inconspicuous nucleus
associated with late acute inflammation and chronic inflammation (including granulomas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Granuloma

A

organised collection of activated macrophages
become more secretory rather than phagocytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How to tell if sputum sample is actually from alveoli?

A

if contains macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stain for TB

A

acid fast stain
Ziehl-Neelson
(red)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ontological classification

A

classified according to cells of origins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Types of carcinomas

A

= malignant tumours of epithelial cells
most common tumours seen
1. squamous cell carcinoma
2. Adenocarcinoma
3. Transitional cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Squamous cell carcinoma

A

keratin production (not always)
intercellular bridges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adenocarcinoma

A

mucin production
glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sites of origin of squamous cell carcinomas

A

skin
head and neck
oesophagus
anus
cervix
vagina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sites of origin of adenocarcinoma

A

lung
breast
pancreas
colon
stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Prussian blue stain

A

stains for ferritin (iron)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Congo red stain

A

amyloid
under polarised light: apple green birefringence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CD45

A

lymphoid marker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Van den bergh test

A

measures serum bilirubin via fractionation
direct reaction measures conjugated bilirubin (addition of methanol causes a complete reaction which measures total bilirubin)
indirect reaction measures unconjugated bilirubin (the difference)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Paediatric jaundice

A

usually normal due to immaturity of liver and fall of Hb in early life so bilirubin will be high and unconjugated
if it doesn’t settle, may be caused by something else eg. hypothyroidism or other causes of haemolysis (do coombe’s or DAT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

why do we use phototherapy for unconjugated bilirubinaema?

A

skin can also conjugate bilirubin
can convert bilirubin into 2 other compounds: lumirubin and photobilirubin which are isomers that do not need excretion or conjugation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Gilbert’s syndrome

A

quite common
recessive inheritance
raised bilirubin with all other LFTs normal
bilirubin increases with fasting and decreased by phenobarb
50% of people carry the gene
prevalence in population is 5.6%
don’t need biopsy or USS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Gilbert’s pathology

A

UDP glucoronyl transferase activity reduced to 30%
unconjugated bilirubin is tightly bound to albumin and does not enter urine
NB: will still have urobilinogen in urine as entero-hepatic circulation is still functional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

No urobilinogen in the urine

A

obstructive jaundice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Aspartate aminotransferase (AST)
takes the amino acid off aspartate and converts into a glucose derivative
26
Alanine aminotransferase (ALT)
takes amino acid off alanine when liver is damaged, leaks into the blood
27
What is most representative of liver function
Prothrombin time (liver makes clotting factors) also albumin because made by liver and bilirubin because metabolised by liver liver enzymes (ALT, AST, ALP, GGT) don't actually tell you about liver function but leak out when liver is damaged NB: in paracetamol overdose, PT determines prognosis (if high, will need transplant)
28
Hepatitis A serology
virus in faeces incubation period become infective immune response begins: IgM start to get jaundiced and symptomatic IgG response begins at 5-weeks post-exposure immune for life vaccine available
29
Hepatitis B serology - acute
2 forms: acute (like Hep A) and chronic acute: become unwell 2-months post exposure, increased HBs Ag and HBe Ag then start antibody response with anti-HBc, HBs and HBe (only when antigen titre reaches 0 for corresponding antigen) - end up with 3 antibodies and no antigen, probably won't get it again but may be a carrier vaccine is against surface antigen (anti-HBs, won't have HBe antibody)
30
Chronic hepatitis B (carriers)
surface antigen remains for years remains infectious to others only have anti-HBc and anti-HBe but not anti-HBs as remain antigenic cannot undergo surgery due to infectious risk
31
Alcoholic hepatitis (histology)
neutrophilic inflammation balloon cells with mallory's hyaline (pink cells) - damaged hepatocytes alcoholic fatty liver is reversible but alcoholic hepatitis may not be reversible may see fatty change left over from early stages positive blue collagen stain - high risk of end-stage liver disease (cirrhosis) megamitochondria (big and swollen - damage due to alcohol)
32
NASH (non-alcoholic steatohepatitis)
commonest cause of fatty liver disease today causes: overweight, malnourished same histological features as alcoholic hepatitis associated with high BMI and diabetes 10% of people with normal BMI also have it
33
Alcoholic hepatitis treatment
supportive: stop alcohol nutrition: vitamins esp b1(IV pabrinex) occasionally steroids liver hepatocytes will regenerate (as long as alcohol stops) - not uniform distribution with hexagonal arrangement and portal triads so may develop cirrhotic nodules (regenerating hepatocytes) eventually leading to portal hypertension (continued cycle of drinking alcohol)
34
Vitamin B1 deficiency
Beri-Beri
35
Vitamin B3 (niacin) deficiency
Pellagra
36
Gynaecomastia in liver disease mechanism
liver breaks down oestradiol, dysfunctional liver leads to build-up of oestradiol and decreased testosterone, causing gynaecomastia
37
Signs of chronic stable liver disease
spider naevi palmar erythema gynaecomastia dupuytren's contracture (alcohol)
38
Signs of portal hypertension
1.visible veins on the abdominal wall 2. splenomegaly (portal vein includes splenic vein) 3. ascites NB: caput medusae from umbilicus (damage to portal triads causes high pressure in umbilical vein because blood can't leave liver through artery so blood travels back down through the portal vein and ductus venosus to the umbilicus)
39
Non-shifting dullness
normal - fat (doesn't move)
40
Shifting dullness
= ascites sign of portal hypertension
41
Flapping tremor
sign of liver failure possibly caused by ammonia but unsure (same flap as CO2 retention)
42
Liver failure
failed synthetic function failed clotting factor and albumin production failed clearance of bilirubin (jaundice) failed clearance of ammonia (encephalopathy) need to decrease protein intake and minimise risk of GI bleed but many die treatment: liver transplant
43
Portal hypertension histopathology
micro or macro cirrhotic nodules (caused by regenerating hepatocytes) surrounded by a fibrous fat cuff characteristic of alcohol pathology fatty changes are reversible scarring in hepatocytes between portal vein and hepatic vein therefore blood entering liver completely bypasses hepatocytes (intrahepatic shunting of blood) - blood isn't filtered and liver is not receiving blood NB: caput medusae and visible veins on abdomen = extrahepatic shunting of blood
44
Progression of alcoholic liver disease
Alcoholic hepatitis (reversible) Chronic stable liver disease (cycle) Portal hypertension Liver failure (end-stage)
45
Portosystemic anastamoses sites & portal hypertension consequences
oesophagus (portal hypertension causes varices - if they tear, bleed to death because no muscle in them) rectal varices umbilical vein recanalising spleno-renal shunt
46
Causes of itching/scratch marks in liver pathology
obstruction of bile ducts only (not just jaundice) - causes by bile salts not bilirubin bile salts/acids emulsify fats and are reabsorbed in the entero-hepatic circulation but when there's an obstruction of the bile duct, bile salts/acids enter the systemic circulation and make you itch
47
Courvoisier's law
if a gallbladder is palpable in a jaundiced patient the cause is likely pancreatic cancer and not gall stones (gall stones cause a small, shrunken, fibrotic gallbladder so won't be palpable)
47
Pancreatic cancer investigations
Abdo USS: dilated bile ducts metastasis
48
Pancreatic carcinoma histopathology
fibrous white tumour tissue metastasis through lymphatics multiple tumour deposits in liver (likely to be secondary as there are multiple deposits) - rapid metastasis through portal vein usually adenocarcinoma (glandular)
49
Normal breast histology
Rule of 2s: 2 main structures: - Large ducts - TDLU (terminal ductus lobular unit) 2 types of epithelial cells: - luminal cells - myoepithelial cells 2 types of stroma: - interlobular stroma (found between ductules and acini) - intralobular stroma Lactiferous ducts divide into extra and intra-lobular terminal ducts which further divide into acini and ductules
50
Terminal duct lobular unit
= extralobular terminal duct with lobule = functional unit of the breast
51
Acinus histology
glandular structure lined by outer myoepithelial cell layer and inner luminal cell layer
52
Presentation of breast disease
breast lump abnormal screening mammogram nipple discharge most problems are benign but breast cancer is second biggest cancer killes
53
Investigating breast disease
triple assessment: physical exam imaging (sonography, mammography, MRI) pathology (cyto/histopathology)
54
Cytopathology in breast disease
indicated if palpable lump or nipple discharge
55
Nipple discharge cytology
papilloma is most common breast lesion that presents with nipple discharge weak association with cancer but increased if discharge is bloody or associated with lump
56
FNA cytology in breast
safe, reliable, accurate, fast, cost-effective, almost complication-free good cellular detail and quick to prepare but cannot differentiate atypical ductal hyperplasia from low grade cancer or high grade in situ carcinoma from invasive cancer ancillary testing not always possible
57
Cytopathology grading breast lumps
C1- inadequate C2 - benign C3 - atypia, probably benign C4- suspicious of malignancy C5 - malignant
58
Histopathology for breast
intact tissue is removed, fixed in formalin, embedded in paraffin wax, thinly sliced and stained with H&E includes biopsies and surgical excisions takes 24 hours to process gives architectural and cellular detail
59
Histopathology breast grading (biopsies only)
B1 - normal tissue / inadequate sample B2 - benign lesion B3 - uncertain malignant potential (need to follow-up with surgical excision eg.) B4 - suspicious of malignancy B5 - malignant
60
Acute mastitis
acute inflammation in the breast usually seen in context of lactation due to cracked skin and stasis of milk may complicate duct ectasis or abscess staph is usual organisms painful red breast (unilateral) drainage and antibiotics histology: lots of inflammatory cells (neutrophils) - may obscure view of normal breast tissue, gram positive
61
Duct ectasia
5th-6th decade, multiparous women inflammation and dilation of large breast ducts aetiology unclear usually presents with nipple discharge sometimes: breast pain, breast mass, nipple retraction benign with no increased risk of malignancy cytology (of nipple discharge): proteinaceous material and inflammatory cells only can give rise to giant cell reaction
62
Fat necrosis (breast)
An inflammatory reaction to damaged adipose tissue. Caused by trauma, surgery, radiotherapy. Presents with a breast mass, late stages may show focal calcification. Benign condition. histology: lipid vacuoles surrounded by inflammatory cells (macrophages and large cells)
63
Galactocele
Cystic dilation of a duct during lactation Usually multiple ducts Tender palpable nodules Secondary infection may convert these to acute mastitis or abscess
64
Proliferative breast diseases
A diverse group of intraductal proliferative lesions of the breast associated with an increased risk, of greatly different magnitudes, for subsequent development of invasive breast carcinoma. Microscopic lesions which usually produce no symptoms. Diagnosed in breast tissue removed for other reasons or on screening mammograms if they calcify. most common = fibrocystic disease
65
Fibrocystic disease (breast)
A group of alterations in the breast which reflect normal, albeit exaggerated, responses to hormonal influences. Very common. Presents with breast lumpiness. No increased risk for subsequent breast carcinoma. histology: fibrous tissue, large cystic glands, adenosis (increased number of glands), may also get apocrine metaplasias
66
Radial scar
A benign sclerosing lesion characterised by a central zone of scarring surrounded by a radiating zone of proliferating glandular tissue. Range in size from tiny microscopic lesions to large clinically apparent masses. Lesions >1 cm are sometimes called “complex sclerosing lesions”. Reasonably common lesions. Thought to represent an exuberant reparative phenomenon in response to areas of tissue damage in the breast. Usually present as stellate masses on screening mammograms which may closely a carcinoma. Excision is curative. Scar is a misnomer; not related to prior trauma or surgery Radiological presents as spiculated mass, architectural distortion, may be indistinguishable from invasive carcinoma – often biopsied Associated risk with invasive breast cancer debated
67
Usual epithelial hyperpalasia
Not considered a direct precursor lesion to invasive breast carcinoma but is a marker for a slightly increased risk (relative risk of 1.5-2.0) for subsequent invasive carcinoma Proliferation of cells of luminal and myoepithelial lineages Cytologic features Mild variation in cellular and nuclear size and shape Architectural features Cohesive proliferation with haphazard, jumbled cell arrangement or streaming growth pattern, Irregular slit-like fenestrations are common, especially along periphery
68
Flat epithelial atypia
Emerging genetic data suggests FEA may represent the earliest morphological precursor to low grade ductal carcinoma in situ. relative risk ~1.5 of developing cancer Frequent secretions and calcifications within cystically dilated glands One to several layers of low columnar or cuboidal cells with low grade cytologic atypia Prominent apical tufting (snouts) Nuclei are usually round with variably prominent nucleoli
69
In-situ lobular neoplasia
Current evidence suggests that in situ lobular neoplasia is a risk factor for subsequent invasive breast carcinoma in either breast in a minority of women. The relative risk is quoted as between 8-10 times that expected in women without lobular neCurrent evidence suggests that in situ lobular neoplasia is a risk factor for subsequent invasive breast carcinoma in either breast in a minority of women. The relative risk is quoted as between 8-10 times that expected in women without lobular neoplasia. More commonly diagnosed in the 50s Does NOT form a palpable mass Solid, (so no arcades, lumens or papillary projections) discohesive proliferation of cells that are monomorphic, small, have pale pink cytoplasm, uniform oval nuclei and indistinct nucleoli, distends >50% of the acini in the lobule
70
Fibroadenoma
A benign neoplasm composed of fibrous and glandular tissue. Common. Presents as a circumscribed mobile breast lump in young women aged 20-30. Simple “shelling out” curative. cytology: stromal naked cells (no cytoplasm), luminal cells (honeycomb epithelial cells), Antlo-horn formations (reassuring its benign) histology: fibrous tissue around ducts or stromal overgrowth compressing ducts
71
Phyllodes tumours
A group of potentially aggressive fibroepithelial neoplasms of the breast. Uncommon tumours. Present as enlarging masses in women aged over 50. Some may arise within pre-existing fibroadenomas. Vast majority behave in a benign fashion, but a small proportion can behave more aggressively. cytology: only stromal cells (no glandular features) histology: increasing stromal proliferation --> leaf-like architecture
72
Intraductal papilloma
A benign papillary tumour arising within the duct system of the breast. Arise within small terminal ductules (peripheral papillomas) or larger lactiferous ducts (central papillomas). Common. Seen mostly in women aged 40-60. Central papillomas present with nipple discharge. Peripheral papillomas may remain clinically silent if small. Excision of involved duct is curative. cytology: Large stellate tissue fragments of benign ductal cells in a proteinaceous background histology:  intraductal proliferation comprised of arborizing fibrovascular cores lined by outer layer of luminal cells and an inner layer of myoepithelial cells Myoepithelial cells also present at the periphery of the involved duct associated with usual type ductal hyperplasia and apocrine metaplasia, less frequently squamous, osseous or chondroid metaplasia may be seen May undergo ischemic or hemorrhagic changes, either spontaneously or secondary to biopsy / trauma May show prominent fibrosis / sclerosis which may contained entrapped glands (sclerosing papilloma)
73
Paget disease of nipple
Proliferation of malignant glandular epithelial cells (in situ carcinoma) in the nipple areolar epidermis. Uncommon clinical presentation of breast cancer, occurs in 1 - 4% of women and 1 - 2% of men Peak incidence between 6th and 7th decade. Pathogenesis: Epidermotropic theory (most widely accepted) - Paget cells are DCIS cells that migrate along the basement membrane of the nipple, supported by the presence of DCIS deeper in the breast identical to Paget cells in almost all cases; Transformation theory - Paget cells originate from malignant transformation of keratinocytes or Toker cells; it would explain rare cases (< 5%) in which cancer is not present in underlying breast - could also be due to biopsy not sampling cancer cells Underlying high grade DCIS or invasive carcinoma is present in > 95% of patients. Majority of Paget cells and associated underlying carcinoma are HER2+
74
Paget disease presentation & histology
Nipple areolar complex with red-pink crusting lesion, discoloration, thickening, ulceration, exudate, nipple retraction Paget cells have abundant pale, clear cytoplasm, which often contains mucin. The nuclei are large and show prominent nucleoli. Paget cells are typically present at the basal portion of the epidermis but can extend throughout the entire thickness and be present very superficially.
75
Ductal carcinoma in situ (DCIS)
A neoplastic intraductal epithelial proliferation in the breast with an inherent, but not inevitable, risk of progression to invasive breast carcinoma (2 - 8.6 times). Common. Incidence has markedly increased since the introduction of breast screening programs. 85% are detected on mammography as areas of microcalcification. 10% produce clinical findings such as a lump, nipple discharge, or eczematous change of the nipple (Paget’s disease of the nipple). 5% are diagnosed incidentally in breast specimens removed for other reasons. Subclassified histologically into low, intermediate and high grade. Treatment is surgical excision. Complete excision with clear margins is curative. Recurrence is more likely with extensive disease and high grade DCIS.
76
Low grade DCIS
Fenestrated proliferation with multiple, round, rigid extracellular lumens with punched out appearance Neoplastic cells are frequently evenly distributed equidistant and polarized with long axis of cell perpendicular to the central lumen Monotonous, round nuclei with smooth contours, small size nuclei
77
High grade DCIS
Lumen of ducts or lobules filled with sheets of cohesive cells Cells are evenly spaced especially in low or intermediate grade DCIS Prominent pleomorphism, large size nuclei  Comedonecrosis (central necrosis with specks of calcification)
78
Invasive breast carcinomas
A group of malignant epithelial tumours which infiltrate within the breast and have the capacity to spread to distant sites. The most common cancer in women with a lifetime risk of 1 in 8. Incidence rates rise rapidly with increasing age, such that most cases occur in older women. Aetiology: Early menarche, late menopause, increased weight, high alcohol consumption, oral contraceptive use, and a positive family history are all associated with increased risk. About 5% show clear evidence of inheritance. BRCA mutations cause a lifetime risk of invasive breast carcinoma of up to 85%. Presentation: Most cases present symptomatically with a breast lump. An increasing proportion of asymptomatic cases are detected on screening mammography.
79
Invasive ductal carcinoma
Most common type of invasive breast carcinoma (75 - 80%). Majority are sporadic; 5 - 10% of all breast cancers are associated with hereditary cancer susceptibility genes lacks the histologic features to classify morphologically as a special subtype of breast cancer Cytology - cellular pleomorphism, nuclear size, nucleoli, lack of naked nuclei, cellular dyscohesion and mitoses & necrosis
80
Invasive lobular carcinoma
Comprises about 10% of invasive breast carcinomas Most common special subtype of invasive breast carcinoma Only comprises 1% of male breast carcinomas  More frequently bilateral and multifocal (need MRI of other breast to identify if another lesion) histology: monotonous proliferation of cells distending the ducts --> break basement membrane and into adjacent stroma --> indian filing (nuclei on top of eachother)
81
Invasive tubular carcinoma
A well differentiated variant with very favorable prognosis Histology: irregular angulated contours of glands ("teardrop-like"), open lumina with apocrine-like snouts and basophilic secretions 
82
Invasive mucinous carcinoma
Clusters / nests of tumor cells with low or intermediate nuclear grade floating in pools of extracellular mucin,  associated with favorable prognosis
83
Basal-like breast carcinoma
Recently described type of carcinoma discovered following genetic analysis of breast carcinomas. Histologically characterised by sheets of markedly atypical cells with a prominent lymphocytic infiltrate. Central necrosis is common. Immunohistochemically characterised by positivity for “basal” cytokeratins CK5/6 and CK14. Often associated with BRCA mutations. Seem to have particular propensity to vascular invasion and distant metastatic spread.
84
Invasive breast cancers histological grading
graded histologically by assessing 1) tubule formation 2) nuclear pleomorphism, and 3)mitotic activity.  Each parameter is scored from 1-3 and the three values are added together to produce total scores from 3-9. 3-5 points = grade 1 (well differentiated). 6-7 points = grade 2 (moderately differentiated). 8-9 points = grade 3 (poorly differentiated). Histologic grading is based on the Nottingham / modified Bloom & Richardson Score 
85
Assessing receptor status of breast cancers
All invasive breast carcinomas are assessed for oestrogen receptor (ER), progesterone receptor (PR) and Her2 status. Low grade tumours tend to be ER/PR positive and Her2 negative. High grade tumours tend to be ER/PR negative and Her2 positive. Basal-like carcinomas are often ER/PR/Her2 negative (“triple negative”).
86
Breast cancer prognosis
The single most important prognostic factor is the status of the axillary lymph nodes. Other important factors include tumour size, histological type, and histological grade.
87
NHS Breast screening programme (BSP)
The aim of screening is to pick up DCIS or early invasive carcinomas. Women aged 50-71 are invited for screening every three years. The screening test is a mammogram which looks for abnormal areas of calcification or a mass within the breast. About 5% of women have an abnormal mammogram and are recalled to an assessment clinic for further investigation. This may include more mammograms, or an ultrasound followed by sampling of the abnormal area, usually by core biopsy. - given b grade --> B4 and B5 need further investigation (B5a = DCIS, B5b = invasive carcinoma, B5c = certain it is malignant but cannot tell if DCIS or invasive)
88
Male breast histology
Composed of ductal structures only within collagenized stroma, with no / rare acini (no/very rare diseases that affect acini) pathologies: gynaecomastia and male breast cancer
89
Male gynaecomastia
Refers to enlargement of the male breast. Pubertal boys and older men aged over 50. Idiopathic or associated with drugs (both therapeutic and recreational). Histologically the breast ducts show epithelial hyperplasia with typical finger-like projections extending into the duct lumen. The periductal stromal is often cellular and oedematous. Benign, no risk of malignancy.
90
Male breast cancer
rare (0.2% of all cancers). Median age at diagnosis 65 years old. Most present with a palpable lump. Histologically the tumors show similar features to female breast cancers. (lobular cancers rare due to lack of lobules)
91
New breast cancer predictive methods
Oncotype DX assay is a genomic test that predicts adjuvant (radiotx for DCIS, Chemotx/radiotx for IDC) therapy benefit and the likelihood of 10-year breast cancer local recurrence risk in patients with DCIS treated with breast conserving surgery and low stage ER positive invasive breast cancers Novel biomarkers not used in routine clinical practice High Ki67 proliferation index has reported to correlate with increased recurrence risk tumor immune microenvironment is an important factor in identifying DCIS cases with the highest risk for recurrence 
92
Normal oesophagus histology
lined by stratified squamous epithelium transition into columnar epithelium of stomach: Z-line
93
Acute oesophagitis histology
oedema neutrophils (inflammatory cells) causes: alcohol, drugs, GORD appearance on endoscopy: red and inflamed
94
Complications of reflux oesophagitis
ulceration (goes through muscularis into submucosa wheras erosion is superficial) haemorrhage perforation stricture Barrett’s oesophagus
95
Barrett's Oesophagus
The same as columnar lined oesophagus (CLO) Replacement of squamous epithelium by metaplastic columnar epithelium: 2 types: - without goblet cells = gastric metaplasia - with goblet cells = intestinal type metaplasia Flat pathway: metaplasia -> LGD -> HGD -> adenocarcinoma (want to diagnose at metaplasia or dysplasia stage due to very poor prognosis)
96
Adenocarcinoma of oesophagus
The commonest oesophageal carcinoma in Developed Countries Associated with reflux (flat pathway) Lower oesophagus --> commonly at gastro-oesophageal junction
97
Squamous cell carcinoma of oesophagus
Commonest oesophageal cancer in Developing Countries Associated with alcohol and smoking Mid/lower oesophagus (higher up than adenocarcinoma) also association with HPV histology: production of keratin, intercellular bridges
98
Oesophageal varices
= varicose veins in oesophagus associated with portal hypertension (caused by extrahepatic shunting of blood) important cause of mortality and morbidity
99
Normal stomach (body) histology
lined by gastric mucosa columnar epithelium (foveolar, mucin secreting) specialised glands in the lamina propria (secrete IF, acid, pepsinogen) muscularis mucosae
100
Normal stomach (antral) histology
lined by gastric mucosa columnar epithelium (fovelolar, mucin secreting) Non-specialised glands in the lamina propria (gastric pits) mucularis mucosae
101
Acute Gastritis causes
Chemical: aspirin/NSAIDs alcohol corrosives Infection: e.g. Helicobacter pylori
102
Causes of chronic gastritis
Autoimmune (antiparietal antibodies etc. body) Bacterial (H. pylori; antrum ) Chemical (NSAIDs, bile reflux; antrum)
103
Other causes of gastritis
Infection e.g. CMV (commonest opportunistic viral pathogen), strongyloides (worms) Inflammatory bowel disease Crohn’s Disease (gastric involvement more common in children)
104
Helicobacter associated gastritis
Cause H. pylori Pattern chronic gastritis +/- activity Outcome Peptic ulcer (gastric and duodenal) - commonest cause Metaplasia +/- dysplasia, Adenocarcinoma Lymphoma (MALToma) - can be reversible if treat helicobacter
105
Complications of ulcers
Bleeding Anaemia Shock (massive haemorrhage) Perforation Peritonitis Cancer (rare)
106
Helicobacter as a carcinogen
Helicobacter infection is associated with an 8x increased risk of (non-cardia) gastric cancer cag-A-positive H.pylori have a needle like appendage that injects toxin into intercellular junctions allowing the bacteria to attach more easily. This strain is associated with more chronic inflammation. Treatment of the infection with antibiotics drastically reduces the risk of cancer.
107
Flat dysplasia pathway in stomach
chronic gastritis --> intestinal metaplasia --> dysplasia --> cancer
108
Intestinal metaplasia
Presence of goblet and Paneth cells In response to chronic gastritis Increased cancer risk (if significantly widespread --> need careful follow-up)
109
Gastric epithelial dysplasia
Abnormal epithelial pattern of growth Some of the cytological and histological features of malignancy are present, but no invasive through the basement membrane
110
Gastric cancer
High incidence in Japan, Chile, Italy, China, Portugal, Russia More common in men (1.8:1 ♂:♀)   >95% of all malignant tumors in stomach are adenocarcinomas (glandular - secrete mucin) These are split morphologically into: - Intestinal – form glands, well differentiated - Diffuse – poorly differentiated (Linitis plastica), includes signet ring cell carcinoma The remaining 5% is mainly made up of: - Lymphoma (MALToma) - Gastrointestinal stromal tumour (GIST) - Neuroendocrine tumours (mostly in terminal ileum)
111
Gastric MALToma / Lymphoma
Chronic inflammation - Chronic immune stimulation B cell (marginal zone) lymphocytes Treatment - If limited to the stomach and H.pylori is present: H.pylori eradication
112
Gastro-intestinal stromal tumour (GIST)
Derived from the interstitial cells of Cajal. Spindle cell tumours Stain with CD117 (not smooth muscle actin) Anywhere in the GIT but stomach is the commonest site. Prognosis depends on site (stomach best), size (the smaller the better) and mitotic index (the lower the better)
113
Normal duodenum histology
Glandular epithelium with goblet cells (intestinal type epithelium) Villous architecture villous:crypt ratio of >2:1
114
Duodenitis, duodenal ulcers and H. pylori
Increased acid production in the stomach which spills over into duodenum Chronic inflammation and gastric metaplasia with helicobacter infection no significant risk of dysplasia and cancer
115
Other pathogens causing duodenitis and duodenal ulcers
Immunosuppressed CMV Cryptosporidiosis Giardia lamblia infection Whipple’s disease -Tropheryma whippelii.
116
Malabsorption - partial villous atrophy (coeliac)
Histology - Villous atrophy - Crypt hyperplasia - Increased Intraepithelial lymphocytes (normal range less than 20 lymphocytes /100 enterocytes)
117
Coeliac disease
Diagnosis requires: endomysial antibodies and tissue transglutaminase antibodies Duodenal biopsies: - On gluten rich diet showing villous atrophy - Off gluten showing normal villi (can make it difficult to diagnose if pt has already stopped consuming gluten) There are other causes of malabsorption with similar histology e.g. tropical sprue (from developed countries go to developing countries and exposed to new mircobiome), drugs
118
Duodenal MALToma/ Lymphoma
Patients with coeliac disease have an increased risk of GIT cancers MALToma associated with Coeliac is in the duodenum T-cell origin (Enteropathy Associated T-cell Lymphoma) histology: big nuclei and lots of nucleoli
119
120
Pancreatic histology
Exocrine: ducts and acini Endocrine: islets of langerhan cells, alpha and beta cells
121
Acute pancreatitis
Acute inflammation of the pancreas caused by aberrant release of pancreatic enzymes. (can lead to positive feedback loop) Relatively common, incidence increasing. Causes: Duct obstruction: - Gall stones (50%) - Trauma - Tumours Metabolic/toxic: - Alcohol (33%) - 5% of alcoholics develop acute pancreatitis - Drugs (e.g. thiazides) - Hypercalcaemia - Hyperlipidaemia Poor blood supply: - Shock - Hypothermia Infection/ inflammation: - Viruses (e.g. mumps) Autoimmune Idiopathic (15%)
122
Acute pancreatitis pathogenesis
2 major pathways: (1) Duct obstruction: - Gallstone stuck distal to where the common bile duct and pancreatic ducts join leads to: reflux of bile up the pancreatic duct followed by damage to acini and release of proenzymes which then become activated - Alcohol leads to spasm/oedema of Sphincter of Oddi and the formation of a protein rich pancreatic fluid which obstructs the pancreatic ducts (2) Direct acinar injury (eg. mumps) --> rest of causes
123
Patterns of injury in acute pancreatitis
Periductal - necrosis of acinar cells near ducts (usually secondary to obstruction) Perilobular – necrosis at the edges of the lobules (usually due to poor blood supply) Panlobular – develops from both of the above Activated enzymes --> acinar necrosis --> enzyme release etc. Ranges from stromal oedema, to haemorrhagic necrosis   e.g. Lipases --> fat necrosis: 1. Lipase splits triglycerides into glycerol and free fatty acids 2. calcium ions bind to the free fatty acids forming soaps which are seen as yellow-white foci (calcium levels will be normal as being used up to bind to fatty acids unless cause of pancreatitis was hypercalcaemia in which case the calcium may be normal)
124
Complications and prognosis of acute pancreatitis
Complications  Pancreatic : pseudocyst (lacks an epithelial lining, fluid-filled, localised and looks like a cyst), abscess (very infected pseudocyst) Systemic: shock, hypoglycaemia (damage to islets), hypocalcaemia (calcium binds to free fatty acids forming fat necrosis)   Prognosis Overall mortality up to 50% for haemorrhagic pancreatitis
125
Chronic pancreatitis
Relapsing or persistent, associated with acute pancreatitis in half of cases Relatively uncommon Mortality 3% per year Causes: Metabolic/toxic: - Alcohol (80%) - Haemochromatosis (iron deposition in pancreas causing damage) Duct obstruction: - Gallstones - Abnormal pancreatic duct anatomy - Cystic fibrosis (“mucoviscoidosis”) - thick secretions causing obstruction Tumours Idiopathic Autoimmune
126
Pathogenesis & Pattern of injury for chronic pancreatitis
Pathogenesis = same as acute but with fibrosis and atrophy , loss of acini --> loss of secretory function Pattern of injury: Chronic inflammation with parenchymal fibrosis and loss of parenchyma Duct strictures with calcified stones with secondary dilatations
127
Complications of chronic pancreatitis
Malabsorption (loss of exocrine function) Diabetes mellitus (eventual loss of islets of langherhans) Pseudocyst Carcinoma of the pancreas (?) (multi-directional ie. can both cause eachother)
128
Pancreatic pseudocyst
Associated with acute and/ or chronic pancreatitis Lined by fibrous tissue (no epithelial lining), contain fluid rich in pancreatic enzymes or necrotic material Connect with pancreatic ducts May resolve, compress adjacent structures, become infected or perforate (-> peritonitis)
129
Autoimmune pancreatitis
= IgG4 related diseases Characterised by large numbers of IgG4 positive plasma cells. May involve the pancreas, bile ducts and almost any other part of the body. Benign
130
Tumours of the pancreas
3 categories: Carcinomas - Ductal (85% of all neoplasms) - Acinar Cystic neoplasms - Serous cystadenoma - Mucinous cystic neoplasm Pancreatic neuroendocrine tumours (Islet cell tumours)
131
Risk factors for pancreatic carcinoma
Smoking BMI and dietary factors Chronic pancreatitis Diabetes
132
Pancreatic ductal carcinoma
5% of cancer deaths Increasingly common with age, 2M: 1F 5 year survival: 5% Arise from dysplastic ductal lesions: Pancreatic Intraductal Neoplasia (PanIN) Intraducal Mucinous Papillary Neoplasm (IMPN) K-Ras mutations in 95% of cases
133
Ductal carcinoma histopathology
Macroscopic Appearance - Gritty and grey - Invades adjacent structures - Tumours in the head present earlier (early obstruction and clinical presentation)   Microscopic Appearance  Adenocarcinomas: mucin secreting glands set in desmoplastic stroma (response to cancer growing in it) very aggressive: peri-neural invasion (common way of spread)
134
Pancreatic ductal carcinoma sites & spread
Sites: Head (60%) Body Tail Diffuse Spread: Direct: Bile ducts, duodenum Lymphatic: Lymph nodes Blood: Liver Serosa: Peritoneum
135
Complications of ductal pancreatic carcinoma
Due to spread Chronic pancreatitis Venous thrombosis (“migratory thrombophlebitis”)  - hypercoagulable state
136
Cystic tumours
Contain serous or mucin secreting epithelium (cf. ovarian tumours) Usually benign
137
Pancreatic endocrine neoplasms
usually non-secretory (most common secretion = insulin --> present with hypogylcaemia) contain neuroendocrine markers e.g. chromogranin (granules) - can stain for it or measure blood levels (for diagnosis and follow-up) behaviour difficult to predict (usually associated with mitotic index) may be associated with the Multiple Endocrine Neoplasia (MEN) 1 syndrome
138
Insulinomas
derived from beta cells = commonest type of secretory tumour
139
Gall bladder pathology
1. Gall stones 2. Inflammation 3. Cancer All associated with stones stones are very common: 20% of adults
140
Risk factors for gall stones
Age and gender: increasing age, F>M Ethnic and geographic: e.g. Native Americans Hereditary: e.g. disorders of bile metabolism Drugs e.g. oral contraceptive (increased oestrogen) Acquired disorders e.g. rapid weight loss (causing more bile secretion and movement)
141
Types of gall stones
Cholesterol (more than 50% cholesterol) May be single, mostly radiolucent (not picked up on abdo x-ray) Pigment (contain calcium salts of unconjugated bilirubin) Multiple, mostly radio-opaque Mixed type
142
Complications of gall stones
most cause no problems Bile duct obstruction Acute and chronic cholecystitis Gall bladder cancer Pancreatitis
143
Acute cholecystitis
Acute inflammation 90% associated with gall stones
144
Chronic cholecystitis
Chronic inflammation Fibrosis (thick and hard GB wall) Diverticula (mucosa going through muscularis) – Rokitansky-Aschoff sinuses 90% contain gall stones
145
Gall bladder cancer
Adenocarcinomas 90% associated with gall stones most common in Chile and Andes, less common in UK
146
Tumours of the nervous system
CNS: Brain and coverings Spinal cord and coverings Pituitary gland PNS: Small nerves in any organ – usually neurofibromas of soft tissue or skin Large nerves – cranial and spinal nerve schwannomas Most are benign tumours
147
Classification of CNS tumours by origin
Primary: tumours that originated within CNS Secondary: Metastases - 10x more frequent than primary tumours in adults (30% of patients with systemic cancer develop CNS metastases) NB: primary tumours most common CNS tumours in children
148
Classification of CNS tumours by location
EXTRA-AXIAL (coverings) Tumours of bone, cranial soft tissue, meninges, nerves INTRA-AXIAL (parenchyma) Derived from normal cell populations of the CNS: glia, neurons and neuroendocrine cells Derived from other cell types: lymphomas, germ cell tumours WHO grade 1 tend to be more extra-axial WHO grade 2-4 tend to be more intra-axial Glioblastomas grade 4 and have worst prognosis
149
CNS tumours aetiology
Largely unknown Only known environmental factor: Previous radiotherapy to head and neck associated with increased risk of meningiomas (and rarely gliomas) Genetic predisposition <5% of primary brain tumours Familial syndromes: Autosomal dominant inheritance with frequent de novo mutations Some examples: Neurofibromatosis 1 (17q11) neurofibroma, astrocytoma Neurofibromatosis 2 (22q12) schwannoma, meningioma Brain Tumour Polyposis syndrome 1 malignant gliomas Gorlin syndrome (PTCH1, 9q31) medulloblastoma Von Hippel Lindau (3p25) hemangioblastoma
150
CNS tumours clinical presentation
Not specific but can be subtle in slow growing tumours whereas there may be a very short history for malignant tumours Intracranial hypertension: headache vomiting change in mental status Supratentorial: focal neurological deficit seizures personality changes Infratentorial (posterior fossa): cerebellar ataxia long tract signs cranial nerve palsy
151
Neuroimaging
Modalities: CT-scan MR-scan MR-spectroscopy (metabolism) Perfusion MRI Functional MRI PET-scan Uses: Assess tumour type Guide resection & biopsy Assess post-surgery Assess response to treatments Follow-up recurrence and progression
152
Management of CNS tumours
SURGERY: Maximal safe resection with minimal damage to adjacent normal tissue gives best outcome Resection: location, size, number of lesions RADIOTHERAPY: Low and high-grade gliomas, metastases, some benign tumours External fractionated RT, stereotactic radiosurgery CHEMOTHERAPY: Mainly for high-grade gliomas (temozolomide) and lymphomas Biological agents (EGFR inhibitors, PD-L1 inhibitors, etc.)
153
Types of surgery for CNS tumours
Craniotomy for debulking may be sub-total or complete resections remove as much tumour as possible Open biopsy inoperable but approachable tumours (about 1cm of tissue) usually representative Stereotactic biopsy if open biopsy not indicated (about 0.5cm of tissue) tissue may be insufficient
154
WHO classification of CNS tumours
Tumour type: Putative cell of origin or lineage of differentiation Tumour grade: Tumour aggressiveness It is based on morphological criteria of malignancy (proliferative activity, cell differentiation, necrosis) and increasingly on genetic profile Molecular profile: Most tumour types have molecular markers A four-tier system: Grade 1 – benign – long-term survival (eg. meningiomas) Grade 2 – more than 5 yrs Grade 3 – less than 5 yrs Grade 4 – less than 1 yr (eg. glioblastomas) Some tumour types have only one possible grade, but others have more than one
155
CNS cell types and tumours
Astrocytes – astrocytoma Oligodendrocytes – oligodendroglioma Ependyma – ependymoma Neurons- neurocytoma Embryonal cells – medulloblastoma Meningothelial cells – meningioma Schwann cells - schwannoma, neurofibroma
156
Glial tumours
Diffuse gliomas: Grades ≥ 2, adults, supratentorial, malignant progression Astrocytomas (grades 2-4) Oligodendrogliomas (grades 2-3) Circumscribed gliomas: Grades 1-2, children, often posterior fossa, rare malignant transformation Pilocytic astrocytoma (grade 1) Subependymal giant cell astrocytoma (grade1) Ependymomas (usually)
157
Pilocytic astrocytoma
Usually 1st & 2nd decade (account for 20% CNS tumours below 14 yrs) Often cerebellar, optic-hypothalamus, brainstem Genetic profile: BRAF mutation in 70% of PA MRI – well circumscribed, cystic, enhancing lesion Histology: Piloid “hairy” cells Very often Rosenthal fibres Slowly growing, low mitotic activity
158
IDH mutant diffuse gliomas
Patients usually 20-40 yrs Astrocytoma (IDH mutant) and Oligodendroglioma (IDH mutant) Pathogenic point mutation in the IDH1/2 gene IDH mutation is associated with longer survival and a better response to chemotherapy and radiotherapy
159
Astrocytomas
Patients usually 20-40 yrs, cerebral hemispheres Genetic profile: point mutation in IDH1/2 MRI – T1 hypointense, T2 hyperintense, non-enhancing lesion. Low choline/creatinine ratio in MR spectroscopy Histology: low to moderate cellularity Mitotic activity is low. No vascular proliferation or necrosis. IDH1 mutants can be detected Immunocytochemically Progression to higher grades over time
160
Glioblastoma multiforme
Most aggressive and most frequent glioma; incidence increase with age Most patients >50 yrs, cerebral hemispheres Median survival 8 months Genetic profile IDH1 wildtype Common mutations in: TERT, PTEN, EGFR MRI – heterogenous, enhancing post contrast Histology: High cellularity Neoangiogenesis Necrosis
161
Meningiomas
38% of primary CNS tumours Rare in patients < 40, incidence ↑ with age Originate from meningothelial cells of the arachnoid mater Any site of craniospinal axis, can be multiple (NF2) MRI: extraxial, iso-dense, contrast-enhancing 80% Grade 1: benign, recurrence <25% 20% Grade 2: atypical, recurrence 25-50% 1% Grade 3: malignant, recurrence 50-90% (Grading is most useful predictor of recurrence)
162
Mitotic activity (CNS tumours)
Determines grade Mitosis per 10HPF (0.16mm2) <4 = grade 1 4-20 = grade 2 >20 = grade 3
163
CNS metastases
Most frequent CNS tumour in adults (10 x intrinsic tumours) Increasing incidence due to longer survival Often multiple, located at grey/white matter junction and/or leptomeningeal disease May be the first presentation of the disease Origin can be challenging to determine: immunohistochemical markers Any cancer can give CNS metastasis, but most frequent tumours are: lung ca, breast ca, melanoma, renal cell ca Very poor prognosis
164
Medulloblastoma (WHO grade 4)
EMBRYONAL TUMOUR: originates from neuroepithelial cells/neuronal precursors of the cerebellum or dorsal brainstem Rare (2 per 1,000,000 year), but second most common brain malignancy in children; also in young adults Outcome considerably improved with radio-chemotherapy and subtype stratification Histology 4 histological subtypes: classic, nodular/desmoplastic, extensive nodularity, large cell anaplastic 3 molecular subtypes by transcriptome or methylome profiling: WNT-activated, SHH-activated, nonWNT/nonSHH
165
Methylome profile
Most tumours have characteristic patterns of DNA methylation of CpG islands The methylation signature is stable and reflects the tumour cell of origin or early transformed cells - Gives information on tumour type not progression/grade The DNA methylation status of a subset of CpG islands is assessed with DNA arrays and compared to a reference dataset (“Classifier”)
166
Mechanisms of CNS damage
Oedema Hydrocephalus Raised intracranial pressure Stroke - Haemorrhage - Infarction Traumatic brain injury
167
Cerebral Oedema
Excess accumulation of fluid in the brain parenchyma Two main types: - Vasogenic – disruption of the blood brain barrier - Cytotoxic – secondary to cellular injury e.g. hypoxia/ ischemia Result is raised intracranial pressure
168
Hydrocephalus
Non-communicating involves obstruction of flow of CSF (most common site = at cerebral aqueduct) Communicating involves no obstruction but problems with reabsorption of CSF into venous sinuses (often a complication of meningitis)
169
Consequences of raised ICP
ICP is normally 7–15 mm Hg for a supine adult Raised ICP due to space occupying lesions, oedema or both Unyielding bony wall of skull and inflexible dural folds Herniation of brain structures (subfalcine [supratentorial, cingulate cortex herniation through falx cerebri), transtentorial/uncal [at level of midbrain, medial temporal lobe into posterior fossa] and tonsillar [at level of cerebellum passing through foramen magnum])
170
Non-traumatic parenchymal haemorrhage
Haemorrhage into the substance of the brain - rupture of a small intraparenchymal vessel Most common in basal ganglia Hypertension (chronic) account for more than 50% of bleeds Presentation with severe headache, vomiting, rapid loss of consciousness, focal neurological signs (more acute than tumours)
171
Arteriovenous malformation (AVM)
Close interweaving of arterial and venous vessels Occur anywhere in the CNS Present from birth Become symptomatic between 2nd and 5th decade (mean age 31.2 years) Present with haemorrhage, seizures, headache, focal neurological deficits High pressure – MASSIVE BLEEDING!!! Seen on angiography Morbidity after rupture 53-81% - high in eloquent areas Mortality 10-17.6% Treatment: surgery, embolization, radiosurgery
172
Cavernous angioma
“Well-defined malformative lesion composed of closely packed vessels with no parenchyma interposed between vascular spaces” Can be found anywhere in the CNS, usually symptomatic after age 50 Pathogenesis unknown Present with headache, seizures, focal deficits, haemorrhage Low pressure – recurrent bleeds Treatment: surgery
173
Subarachnoid haemorrhage
Rupture of a berry aneurysm (present in 1% of general population) 80 % of berry aneurysms- internal carotid artery bifurcation, 20% occur within the vertebro-basilar circulation 30% of patients have multiple aneurysms Greatest risk of rupture when 6-10mm diameter Present with sudden onset of severe headache ('thunderclap'), vomiting, loss of consciousness Mixed prognosis Treatment: endovascular platinum coil into aneurysm (radiologists through femoral artery)
174
Infarction
Tissue death due to ischemia Commonest form of cerebrovascular disease 70-80% of strokes Cerebral atherosclerosis most common cause hypertension, diabetes, smoking are major risks factors Worst atherosclerosis in larger vessels (extracerebral arteries) – thrombosis Often near carotid bifurcation or in basilar artery Other cause - emboli (intracerebral arteries) Usually from heart or atherosclerotic plaques Embolic occlusion usually in middle cerebral artery branches a) Focal cerebral ischaemia: defined vascular territory b) Global cerebral ischaemia: systemic circulation fails
175
Stroke differential diagnoses
Infarct: Tissue necrosis Rarely haemorrhagic Permanent damage in the affected area No recovery Haemorrhage: Bleeding Dissection of parenchyma Fewer macrophages Limited tissue damage Partial recovery (really important: don't want to give thrombolytics to haemorrhagic patients)
176
Head fractures
Fissure fractures often extend into base of skull May pass through middle ear or anterior cranial fossa (resulting in CSF leakage) Otorrhea or rhinorrhea (may be mixed with blood and therefore less obvious) Battle sign: bruising behind ears due to skull base fracture Infection risk
177
Head contusions
Brain in collision with skull caused by impact Surface “bruising” If pia mater torn, then becomes laceration Lateral surfaces of hemispheres, inferior surfaces of frontal and temporal lobes Coup or contrecoup (rebound causing damage on both the front and back of skull)
178
Diffuse axonal injury
Occurs at moment of injury Shear & tensile forces affecting axons causing white matter damage Commonest cause of coma (when no bleed) Midline structures particularly affected e.g. corpus callosum, rostral brainstem and septum pellucidum
179
Chronic traumatic encephalopathy
multiple repetitive sub-clinical/sub-concussive impacts initiating a neurodegenerative process seen in american football players who presented after retirement with psychiatric/early dementia symptoms now also seen in rugby and football players in the UK
180
Alzheimer's neuropathology
Extracellular plaques (beta amyloid protein, can be diffuse or classic [target-shaped]) Neurofibrillary tangles (Paired helical filaments (PHF), Tau = a microtubule associated protein (MAP), Stabilization of microtubules dependent on phosphorylation state. In AD, tau hyperphosphorylated) Cerebral amyloid angiopathy (CAA) (amyloid in blood vessel walls) Neuronal loss (cerebral atrophy; cortical and hippocampal)
181
ABC Alzheimer's assessment
Amyloid: Where are amyloid plaques found in brain? --> 5 phases given score of 0-3 Braak Staging: neurofibrillary tangles and spread --> 0-3 Counting: How many plaques? --> 0-3 score of 333 = high chance of clinical AD
182
Parkinson's disease
Loss of dopaminergic neurones in substantia nigra in the midbrain (basal ganglia) causing movement disorders and difficulty to initiate movements Build-up of lewy bodies (hyaline inclusions within dopaminergic cells in substantia nigra) Polymeropoulos in 1997 found that mutations in the α-synuclein gene can result in PD Spillantini reported that Lewy bodies and Lewy neurites are immunoreactive for α-synuclein Now α-synuclein immunostaining is considered as the diagnostic gold standard neuro-melanin = by-product of dopaminergic cell metabolism, seen as black line in midbrain sample post-mortem, not seen in parkinson's brains
183
Parkinson's Grading
Braak staging depending on spread throughout brain (from cerebellum upwards to cortices)
184
Parkinsonism
Bradykinesia Rigidity Rest tremor Response to L-dopa
185
Diseases that present with parkinsonism (Parkinsons plus)
Idiopathic Parkinson’s disease Drug-induced parkinsonism Multiple system atrophy Progressive supranuclear palsy Corticobasal degeneration Vascular pseudo-parkinsonism Alzheimer’s changes Frontotemporal neurodegenerative disorders 20 other disorders
186
Multiple system atrophy (MSA)
Term covering three disorders: Olivopontocerebellar atrophy (OPCA) Shy-Drager syndrome (autonomic presentation eg postural hypotension) Striatonigral degeneration (exactly like PD) Now characterised clinically as: MSA-P – predominant parkinsonism MSA-C – cerebellar features Pathology: Cortical atrophy (motor, premotor) Cerebellar atrophy Shrinkage of middle cerebellar peduncle, pons and inferior olivary nucleus Pallor of locus coeruleus and substantia nigra Mixed neuronal and glial pathology α-synuclein immunoreactive glial cytoplasmic inclusions (GCI) Neuronal cytoplasmic inclusions, neuronal nuclear inclusions, glial nuclear inclusions and neuropil threads
187
Corticobasal degeneration (CBD)
Progressive neurodegenerative disorder Rigidity, clumsiness, stiffness and jerking of arm, “alien limb” (feeling like someone else is controlling limb) Affects cerebral cortex (fronto-parietal atrophy), deep cerebellar nuclei and substantia nigra Glial and neuronal inclusions Neuropil threads particularly prominent Pathology: Balloon neurons Astrocytic plaques (Tau pathology not alpha-synuclein)
187
Progressive supranuclear palsy (PSP)
Most common form of atypical parkinsonism Often show no response to L-DOPA Supranuclear gaze palsy & postural instability Atrophy of basal ganglia, subthalamus & brainstem Neuronal loss & gliosis Neuronal & glial tau-positive inclusions Pathology: Tufted astrocytes Coiled bodies (in oligodendrocytes)
188
Pick's disease
Fronto–temporal atrophy Marked gliosis and neuronal loss Balloon neurons Tau positive Pick bodies (small round inclusions within hippocampus) - 3R Tau pathology
189
Prion diseases
Transmissible Spongiform Encephalopathies A series of diseases with common molecular pathology Transmissible factor No DNA or RNA involved Prion (proteinaceous infectious only) eg. CJD (Creutzfeldt-Jakob disease) Pathology: generalised atrophy spongiform change (holes in the tissue) prion protein deposits Conversion of prion from alpha helical formation into beta-pleated sheet, possibly driving pathology Rapid progression, death within a year very rare
190
Pelvic Inflammatory disease (PID)
Gonococci, chlamydia, enteric bacteria usually starts from the lower genital tract and spreads upward via mucosal surface Staph, strept, coliform bacteria and clostridium perfringens secondary to abortion usually start from the uterus and spread by lymphatics and blood vessels upwards deep tissue layer involvement Complications: Peritonitis Bacteraemia Intestinal obstruction due to adhesions Infertility
191
Gynae infections
Cause discomfort but no serious complications: Candida: Diabetes mellitus, oral contraceptives and pregnancy enhance development of infection Tichomonas vaginalis: protozoan Gardenerella: gram negative bacillus causes vaginitis Have serious complications: Chlamydia: major cause of infertility Gonorrhoea: major cause of infertility Mycoplasma: causes spontaneous abortion and chorioamnionitis HPV: implicated in cancer
192
Salpingitis
Acute, Chronic or granulomatous Usually direct ascent from the vagina (except TB) Depending on severity and treatment may result in: Resolution Complications: - Plical fusion - Adhesions to ovary - Tubo-ovarian abscess - Peritonitis - Hydrosalpinx (fluid build-up) - Infertility - Ectopic pregnancy
193
Cervical Cancer
2nd most common cancer affecting women worldwide Mean age 45-50 years Important malignancy to know about: 1. Role of viruses in aetiology of cancer 2. Premalignant phase – (Cervical intraepithelial neoplasia) 3. Role of screening 4. Intervention possible at preinvasive stage 5. Possibility of prevention by vaccination
194
Cervical cancer risk factors
Human Papilloma Virus -present in 95% (low and high risk groups) Many sexual partners Sexually active early Smoking Immunosuppressive disorders
195
Low risk HPVs
Most common types: 6, 11 Other types: 40, 42, 43, 44, 54, 61, 72, 73, 81 Genital and oral warts Low grade cervical dysplasia
195
High risk HPVs
Most common types: 16, 18 Other types: 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68,82 Low & high grade cervical dysplasia Cervical cancer Vulval, vaginal, penile, and anal cancer
196
Cervical intraepithelial neoplasia (CIN)
This is the term for dysplasia in this site Epithelial cells have undergone some phenotypic and genetic changes which are premalignant and preinvasive Basal membrane immediately deep to the surface epithelium is intact Squamous epithelium is involved more often (CIN) than glandular epithelium (CGIN)
197
Cervical carcinoma
Invasion through the basement membrane defines change from CIN to invasive carcinoma Two principal types of cervical carcinoma Squamous cell carcinoma (almost always HPV dependent) Adenocarcinoma (20% of all invasive cases) HPV dependent or independent Prognosis: Tumour stage: FIGO Stage I (90%) – IV (10%) 5 year survival
198
Latent/ Non-productive HPV infection
HPV DNA continues to reside in the basal cells Infectious virions are not produced Replication of viral DNA is coupled to replication of the epithelial cells occurring in concert with replication of the host DNA Complete viral particles are not produced The cellular effects of HPV infection are not seen Infection can only be identified by molecular methods
199
Productive HPV infection
Viral DNA replication occurs independently of host chromosomal DNA synthesis. Large numbers of viral DNA are produced and result in infectious virions. Characteristic cytological and histological features are seen (koilocyte)
200
HPV transformation of cells
Two proteins E6 and E7 encoded by the virus have effects on genes. E6 and E7 bind to and inactivate two tumour suppressor genes: Retinoblastoma gene (Rb) (E7) P53 (E6) Both effects interfere with apoptosis and increase unscheduled cellular proliferation both of which contribute to oncogenesis.
201
HPV vaccine
Helps protect against cancers caused by HPV (e.g. cervical, anal, head & neck) Girls and boys aged 12 to 13 years are offered the HPV vaccine as part of the NHS vaccination programme. In England, they are offered 1st dose in school Year 8 2nd dose offered 6 to 24 months after the 1st dose. It's important to have both doses of the vaccine to be properly protected.
202
Indications for uterine biopsies
Endometrium: Infertility Uterine bleeding Thickened endometrium on imaging Uterus or related mass: Lesion identified on imaging As part of a wider resection
203
Uterine corpus
Congenital anomalies Inflammation: acute or chronic endometritis Adenomyosis Dysfunctional uterine bleeding: e.g. hormonal imbalance Endometrial atrophy and hyperplasia Endometrial polyp Uterine tumours
204
Uterine tumours
Endometrial epithelial tumours and precursors Tumour like lesions; e.g. endometrial polyp Mesenchymal tumours specific to the uterus Mixed epithelial and mesenchymal tumours Miscellaneous tumours
205
Endometrial hyperplasia
Perimenopause Persistent anovulation Polycystic ovary (PCO) Ovarian Granulosa cell tumours ov Oestrogen therapy May be associated with atypia
206
Endometrial cancers
Endometrial cancer is the most common gynaecological malignancy in developed countries, causing 6% of new cancer cases in women. Risk factors: Nulliparity Obesity Diabetes mellitus Excessive oestrogen stimulation Histological subtypes: Endometrioid Serous Clear cell Undifferentiated Mixed cell Mesonephric / mesonephric like Squamous cell Mucinous Carcinosarcoma
207
Endometroid carcinoma
Are oestrogen dependent Often associated with atypical endometrial hyperplasia Low grade and high grade tumours Develop through the accumulation of mutations of different genes
208
Serous and clear cell carcinomas
Older, postmenopausal Less oestrogen dependent Arise in atrophic endometrium High grade, deeper invasion, higher stage Endometrial serous carcinoma: P53 mutations in 90% PI3KCA mutations in 15% Her-2 amplification Clear cell carcinoma: PTEN mutation CTNNB1 mutation Her-2 amplification
209
Endometrial cancer tumour grades
Serous, clear cell, mixed, undifferentiated, dedifferentiated and carcinosarcoma are considered high grade. Endometrioid carcinoma: FIGO 3 tier system: grade 1, 2 and 3 depending on Architecture: % of gland formation Cytological atypia
210
TGCA endometrial cancer tumour classifications
Group 1: EEC with mutations in POLE (Polymerase E- ultramutated) - better prognosis Group 2: EEC with MSI (hypermutated) Group 3: EEC with low copy number alterations Group 4: (serous-like) tumours show TP53 mutations and high copy number alterations - grades 1,2,3 POLE and MSI sensitive to anti-PD1 checkpoint inhibitor (immunotherapy)
211
Leiomyoma
(mesenchymal tumours) Smooth muscle tumour of myometrium Commonest uterine tumour 20% of women >35yrs Lay term is fibroid Usually multiple May be intramural, submucosal or subserosal
212
Leiomyosarcoma
Malignant counterpart of leiomyoma - rare Usually solitary Usually postmenopausal Local invasion and blood stream spread 5yr survival 20-30%
213
Endometriosis
Presence of endometrial glands and stroma outside the uterus Common – 10% of premenopausal women Origin: Metaplasia of pelvic peritoneum Implantation of endometrium, retrograde menstruation Ectopic endometrial tissue is functional and bleeds at time of menstruation > pain, scarring and infertility Can develop hyperplasia and malignancy
214
Ovarian cysts
(mainly) Non neoplastic cysts: Follicular and luteal cysts Polycystic ovarian disease: 3-6% of reproductive age women patients have persistent anovulation obesity and hirsutism / virilism Endometriotic cyst
215
Ovarian tumours (classification)
Primary tumours: Epithelial tumours Sex cord-stromal tumours Germ cell tumours Miscellaneous tumours Secondary tumours
216
Ovarian tumours by age
Epithelial tumours: make up 65% of all ovarian tumours & 95% of malignant ovarian tumours 50% found in 45-65 age group Germ cell tumours: have bimodal distribution; one peak 15-21 year olds and one peak at 65-69 Sex cord stromal tumours: most commonly seen in post-menopausal women but some sub-types peak in 25-30 year age group
217
Benign epithelial tumours (ovarian)
Serous Cystadenomas Cystadenofibromas Mucinous cystadenomas Brenner tumour
218
Borderline epithelial tumours (ovarian)
(Serous, mucinous, endometrioid, clear cell, seromucinous & Brenner) Tumours whose biologic behaviour cannot be predicted on histologic grounds Tumours that have very low but definite metastatic potential Morphologically similar tumours may behave differently To date, there are no reliable histological or molecular predictive markers for the behaviour of these tumours
219
Malignant ovarian epithelial tumours
Worldwide is the 6th most common cancer in women 2nd commonest female cancer causing death in women Difficult to diagnosis at an early stage Develops resistance to therapeutic agents Risk factors: Nulliparity, infertility, early menarche, late menopause. Genetic predisposition: Family history of ovarian and breast cancers
220
Heredity & Ovarian cancer
Up to 10% of epithelial ovarian cancer cases are familial 3 familial syndromes: All are transmitted in an autosomal dominant fashion familial breast-ovarian cancer syndrome site-specific ovarian cancer cancer family syndrome (Lynch type II) Familial breast-ovarian cancer and site-specific ovarian cancer syndromes Associated with mutations of the BRCA1 and BRCA2; account for 90% of familial ovarian cancers Hereditary ovarian cancer occurs at a younger age than sporadic Carriers have 15 fold increase risk of ovarian carcinoma to non-carriers > 90% cancers are of serous: ovarian, peritoneal, fallopian tube.
221
Lynch II syndrome
HNPCC is responsible for 3% of ovarian carcinomas Ovarian cancers associated are mainly of the endometrioid and clear cell types
222
High grade serous (ovarian) carcinoma
Most common type of malignant tumours (80%) Aggressive Alteration in P53, in virtually all BRCA1 or BRCA2 abnormalities (germline and somatic mutations; BRCA1 promoter methylation) These genes encode proteins that play important roles in DNA repair (homologous recombination).
223
BRCA mutations
Identification of hereditary cases. Current data suggests that BRCA2 mutations confer an overall survival advantage compared with either being BRCA-negative or having a BRCA1 mutation in high-grade serous ovarian cancer. BRCA mutation status has a major influence on response to chemotherapy. Patients can benefit from targeted therapy by PARP inhibitors.
224
Low grade serous (ovarian) carcinoma
Distinct pathogenesis from high grade serous carcinoma. Low grade, relatively indolent, arise de novo or from borderline ovarian tumours. Mutations in KRAS, BRAF. No association with BRCA mutations.
225
Mucinous ovarian tumours
Morphological features similar to mucinous tumours of the gastrointestinal tract. KRAS mutations.
226
Secondary ovarian tumours
Metastatic colorectal carcinoma: Ovaries, an anatomic site prone to involvement by metastatic colorectal adenocarcinoma. 4-10% of CRC go to ovary. Ovarian lesions are identified prior to the primary tumor in 14-32% of cases. Krukenberg tumours: Bilateral metastases composed of mucin producing signet ring cells. Most often of gastric origin or breast.
227
Endometrioid Carcinoma
10-20% associated with endometriosis, but most others thought to be derived from surface epithelium Co-existence with endometrioid carcinoma in uterus common Molecular changes CTNNB1 (38%-50%) PTEN (15-20%) KRAS and BRAF (4%-36%) MSI (8-38%) PIK3Ca in (20%) P53 >60% and usually in high Endometriosis is a precursor
228
Clear cell carcinoma
Strong association with endometriosis Molecular changes: MSI (6-21%) PTEN (6%) P53 (8.3%) BRAF (6.3%) PIK3Ca (20-25%) B-catenin (3%)
229
Sex cord stromal tumours
Pure stromal tumours: e.g. Fibroma, Thecoma, microcystic stromal tumour Pure sex cord cells: e.g. Adult type and juvenile granulosa cell tumour Mixed sex cord-stromal tumours: e.g. Sertoli Leydig cell tumour Fibroblasts: Fibromas: benign, no endocrine production Granulosa cells: Granulosa cell tumor variable behaviour, may produce estrogen Thecal cells: Thecoma: benign, may secrete oestrogen, or rarely androgens Sertoli-Leydig cells: Sertoli-Leydig cell tumor variable behaviour, may be androgenic
230
Molecular changes in sex cord stromal tumours
Adult type granulosa cell tumour (GCT): 97% of adult GCT show somatic mutation of the Forkhead transcription factor FOXL2, is a master transcription factor that regulates cell proliferation and apoptosis. FOXL2 mutation can be done in AGCT to confirm the diagnosis in cases where the diagnosis is in question. Mutation in CTNNB1
231
Hereditary predisposition to sex cord stromal tumours
DICER1 Syndrome: Germline mutation in DICER1, a gene encoding an RNAse III endoribonuclease. Familial multinodular goitre with sertoli / leydig cell tumour, and tumour susceptibility includes pleuropulonry blastoma in childhood. Found in up to 60% of seroli-Leydig cell tumours. Peutz Jeghers syndrome: Germline mutations of STK11 Sex cord stromal tumour with annular tubules Cases occurring in PJS usually show indolent behaviour.
232
Mature Teratoma (dermoid)
Benign Solid or cystic May show many lines of differentiation but all mature adult type tissues Teeth and hair very common type of germ cell tumour
233
Immature teratoma
Indicates presence of embryonic elements Neural tissue particularly conspicuous A malignant neoplasm that grows rapidly, penetrates the capsule and forms adhesions to the surrounding structures Spreads in the peritoneal cavity by implantation Metastasis to lymph nodes, lung, liver and other organs Three tier grading system according to amount of primitive elements
234
Mature cystic teratoma with malignant changes
Malignant transformation is rare occurring in 2% of cases, usually in post menopausal women Most frequently squamous cell carcinoma Also carcinoid, thyroid carcinoma, basal cell carcinoma, malignant melanoma, intestinal adenocarcinoma, leiomyosarcoma, chondrosarcoma and angiosarcoma
235
Hirschsprungs disease
Absence of ganglion cells in the submucosal and myenteric plexuses Starts in the rectum which fails to dilate] 80% male Associated with Down’s syndrome (2%) RET proto-oncogene mutation Treatment: resection of affected (constricted) segment with frozen section to identify when the ganglion cells
236
Functions of kidney
excretion fluid and electrolyte balance regulation of blood pressure (renin) regulation of calcium (1,25 alpha hydroxylase) regulation of haematocrit (erythropoieitin)
237
Filtration in glomerulus
high hydrostatic pressure (60mmHg) podocytes create charge-dependent (anionic) and size-dependent barrier normal rate: 125 mL/min
238
Filtration in PCT
sodium actively resorbed hydrogen is exchanged to allow carbonate resorption co-transport of amino acids, phosphate and glucose potassium is also resorbed
239
Filtration in loop of henle
descending/thin ascending limb are permeable to water but not ions or urea, ascending limb actively resorbs sodium and chloride countercurrent multiplier: aligned with vasa recta
240
Filtration in DCT
(impermeable to water) regulates pH via active transport (proton/bicarb) regulates sodium, potassium via active transport (aldosterone) regulates calcium (PTH, 1,25 dihydroxycholecalciferol)
241
Filtration in collecting duct
resorbs water (principal cell, ADH) regulates pH (intercalated cells, proton excretion)
242
Immune complexes in kidney
latticework of antibody and antigen (antigen may be endogenous or exogenous) may deposit in glomerulus and cause: inflammatory response, complement activation, stimulation of inflammatory cells may deposit at different rates and sites
243
Polycystic kidney disease
1:500 Adult dominant 10% of end-stage renal failure presents in adulthood with hypertension, flank pain and haematuria Genetic element: PKD1, PKD2 associated with berry aneurysms
244
Cystic diseases of the kidney
cysts commonly develop in patients with end-stage renal disease who are on dialysis can be: multiple, bilateral, cortical and medullary increased risk of malignancy development (7% risk at 10 years, papillary renal cell carcinoma)
245
Medical renal disease syndromes
acute renal failure (AKI) nephrotic syndrome isolated urinary abnormalities chronic kidney disease
246
Acute renal failure
rapid deterioration in renal function (hours, days) common, often in setting of pre-existing disease causes: - pre-renal: failure of perfusion - renal: acute tubular injury, acute glomerulonephritis, thrombotic microangiopathy - post-renal: obstruction presentation and prognosis are variable
247
Acute tubular injury
commonest cause of AKI tubular epithelial cells are damaged by ischaemia, toxins (contrast, Hb, myoglobin, ethylene glycol), drugs common in critical illness drugs that inhibit vasodilatory prostaglandins (NSAIDs) predispose
248
ATI pathogenesis
normal epithelium with brush border ischaema/toxins cause loss of polarity and brush border apoptosis and sloughing of viable and dead cells proliferation, differentiation, re-polarisation spreading and dedifferentiation of viable cells
249
ATI causing glomerular filtration failure
blockage of tubules by casts leakage of tubules into interstitial space secondary haemodynamic changes
250
Acute Tubulo-interstitial nephritis (ATIN)
immune injury to tubules and interstitium can also be due to infection and drugs: NSAIDs, Abx, diuretics, allopurinol, PPIs heavy interstitial inflammatory infiltrate with tubular injury (can see eosinophils and granulomas)
251
Acute glomerulonephritis
acute inflammation of glomeruli presents with oliguria with urine casts, containing erythrocytes and leucocytes when sufficient to cause AKI, there are almost always crescents (proliferation of cells within Bowman's space)
252
Acute crescentic glomerulonephritis
immune complex anti-GBM disease Pauci-immune (anti-neutrophil cytoplasm antibodies) leads rapidly to irreversible renal failure correct diagnosis and treatment urgent
253
Immune complex associated crescentic glomerulonephritis
aetiologies include SLE, IgA nephropathy and post-infectious immune complexes can be identified and localised with IHC and electron microscopy
254
Anti-GBM disease
rare and severe caused by Abs directed against glomerular basement membrane c-terminal domain of type IV collagen may cross react with alveolar BM leading to pulmonary haemorrhage Abs may be detected with serology linear deposition of IgG demonstrable on GBM
255
Pauci-immune crescentic glomerulonephritis
only scanty glomerular Ig deposits usually ANCA-associated; trigger neutrophil activation and glomerular necrosis vasculitis everywhere
256
Thrombotic microangiopathy (TMA)
damage to endothelium in glomeruli, arterioles, arteries leading to thrombosis red cells may be damaged by fibrin: MAHA, HUS Diarrhoea associated: bacterial gut infections ie E.coli, toxins released that target renal endothelium Non-diarrhoea associated: defectes in complement regulation, ADAMTS13 def, drugs (calcineurin inhib), radiation, HTN, scleroderma, APL Ab syndrome
257
Nephrotic syndrome
breakdown in selectivity of glomerular filtration barrier leading to protein leak Presentation: proteinuria, hypoalbuminaema, oedema, hyperlipidaemia
258
Minimal change disease
(non-immune complex mediated) glomeruli look normal by light microscopy effacement of foot processes on EM common cause of nephrotic syndrome in children generally responds to immunosuppression
259
Focal segmental glomerulosclerosis
(non-immune complex mediated) some glomeruli are partially scarred less likely to respond to immunosuppression must exclude possible other diseases that can produce similar appearance (tend to not be nephrotic)
260
Membranous glomerulonephritis
(immune complex mediated) associated with immune deposits on outside of GBM (subepithelial) common cause of nephrotic syndrome in adults primary disease is autoimmune (Ab against PLA2R) need to exclude possibility of secondary disease (epithelial malignancy, drugs, infections, SLE)
261
Diabetic nephropathy
(systemic nephrotic syndrome) high glucose levels directly injurious typically starts as microalbuminuria before progression to proteinuria and nephrotic syndrome Nodular glomerulosclerosis: - stage 1: thickening of BM on EM - stage 2: increase in mesangial matrix, without nodules - stage 3: nodular lesions / kimmelstiel-wilson - stage 4: advanced glomerulosclerosis commonest cause of renal replacement therapy
262
Amyloidosis
(systemic nephrotic syndrome) deposition of extracellular proteinaceous material exhibiting beta-sheet structure commonest forms in kidney are: - AA; derived from SAA protein, an acute phase protein; tends to have chronic inflammatory state - AL; derived from Ig light chains, 80% have multiple myeloma NB: congo red stain
263
Isolated urinary abnormalities
Microscopic haematuria: - thin basement membranes - IgA nephropathy Asymptomatic proteinuria: - may be associated with broad range of glomerular structural abnormalities or immune complex deposition - diagnosis often requires renal biopsy for histology, IHC or EM
264
Thin basement membranes
hereditary defect in type IV collagen synthesis basement membrane <250nm thickness haematuria is only consequence in most cases Alport's syndrome: - X-linked dominant mutations affecting alpha5 subunit - forms exist in which mutation affect alpha3 or 4 subunit - typically progressive, renal failure in middle age - often have deafness, ocular disease
265
IgA nephropathy
commonest glomerulonephritis IgA predominant mesangial immune complex deposition aetiology not well understood in primary form - secondary forms observed in lover, bowel, skin - can be seen with henoch-schonlein purpura - 30% develop end stage renal failure Scoring: oxford classification
266
CKD
can be caused by a large number of diseases significant cause of morbidity and mortality associated with ischaemic heart disease (HTN, hyperlipidaemia, calcification of blood vessels) association with calcium and phosphate metabolic derangement (hyper PTH, osteomalacia, osteoporosis)
267
Hypertensive nephropathy
pathophysiology not fully understood - narrowing of arteries and arterioles leading to scarring and ischaemia of glomeruli - hypertension in glomeruli leading to altered haemodynamic environment, stress and segmental scarring shrunken kidneys with granular cortices histopath may show nephrosclerosis (arteriolar hyalinosis, arterial intimal thickening, ischaemic glomerular changes, segmental and global glomerulosclerosis)
268
SLE & the kidney
= systemic autoimmune disease affects kidney, skin, joints, heart, serosal surfaces, CNS affects 1/2500 people 9:1 f:m deposition of immune complexes in kidney is common - Abs directed at a broad range of intracellular and extracellular antigens - anti-nuclear and anti-dsDNA Abs are typical
269
SLE classification
I - minimal mesangial disease, near normal on light microscopy II - mesangial proliferative disease; mesangial hypercellularity, at most isolated subepithelial or subendothelial depositis III - focal disease; active or inactive segmental
270
Urinary calculi
crystal aggregates that form in renal CDs - can eb deposited anywhere in urinary tracts
271
Calcium oxalate urinary calculi
related to hypercalciuria
272
Urinary calculi - triple stones
magnesium, ammonium, phosphate
273
Uric acid urinary calculi
hyperuricaemia: gout or rapid cell turnover most patients don't have hyperuricaemia
274
Urinary calculi complications
small stones that stay in kidney may be asymptomatic (otherwise detected during investigation of haematuria or recurrent UTIs)
275
Papillary adenoma
benign epithelial kidney tumour composed of papillae or tubules
276
Renal oncocytoma
benign epithelial kidney tumour composed of oncocytic cells - well circumscribed -
277
Angiomyolipoma
benign mesenchymal kidney tumour composed of thick-walled blood vessels, smooth muscle and fat
278
Renal cell carcinoma
malignant epithelial kidney tumour
279
Renal cell carcinoma subtypes
280
Clear cell renal cell carcinoma
281
Papillary renal cell carcinoma
(no longer divided into two types based on morphology)
282
Chromophobe renal cell carcinoma
283
RCC prognosis
284
Nephroblastoma
(Wilm's tumour)
285
Urothelial carcinoma
(aka TCC)
286
UC subtypes
287
Non-invasive papillary UC
288
Infiltrating UC
289
Flat UC in-situ
by definition; high grade
290
BPH
benign enlargement of prostate as a consequence of increase in cell number
291
BPH presentation
292
Prostatic adenocarcinoma
most common malignant epithelial tumour in men
293
Prostatic adenocarcinoma prognosis
294
Testicular germ cell tumours
highly sensitive to platinum-based chemo excellent prognosis
295
Subtypes of testicular germ cell tumours
seminoma embryonal carcinoma post-pubertal teratoma yolk sac tumour choriocarcinoma
296
Testicular non-germ cell tumours
much less common that germ cell tumours
297
Paratesticular diseases
298
Penile diseases
299
Urethral diseases
300
Scrotal diseases
301
Lower GI mechanical disorders
Obstruction: Adhesions Herniation Extrinsic mass Volvulus Diverticular disease
302
Volvulus
Complete twisting of a loop of bowel at mesenteric base around vascular pedicle Intestinal obstruction +/- infarction Small bowel (infants) Sigmoid colon (elderly)
303
Diverticular disease
High incidence in West Low fibre diet High intraluminal pressure needed to push stool through ‘Weak points’ in wall of bowel where muscular coating is less present 90% occur in left colon
304
Complications of diverticular disease
Pain Diverticulitis Gross perforation Fistula (bowel, bladder, vagina) Obstruction
305
Inflammatory disorders of lower GI tract
Acute colitis: Infection Drug/toxin (especially antibiotic) Chemotherapy Radiation Chronic colitis: Crohn’s Ulcerative colitis TB
306
Infectious colitis causes
Viral e.g. CMV (can colonise and exacerbate IBD) Bacterial e.g. Salmonella Protozoal e.g. Entamoeba hystolytica Fungal e.g. candida
307
Pseudomembranous colitis
Follows antibiotic theraapy Acute colitis with pseudomembrane formation Caused by protein exotoxins of Clostridium difficile Histology: Characteristic microscopic features on biopsy Laboratory: C. difficile toxin stool assay
308
Ischaemic colitis / infarction
Acute or chronic Usually occurs in segments in “watershed” zones, e.g. splenic flexure (SMA and IMA) and the rectosigmoid (IMA and internal iliac artery) Mucosal, mural, transmural (perforation)
309
Ischaemic colitis aetiology
Arterial Occlusion: atheroma, thrombosis, embolism Venous Occlusion: thrombus, hypercoagulable states Small Vessel Disease: emboli, vasculitis Low Flow States: congestive cardiac failure, haemorrhage, shock Obstruction: hernia, intussusception, volvulus, adhesions
310
Chronic IBD aetiology
?Genetic predisposition (familial aggregation, twin studies, HLA ) ?Infection (Mycobacteria, Measles etc) ?Abnormal host immunoreactivity ?Microbiome
311
Chronic IBD clinical features
Diarrhoea +/- blood Fever Abdominal pain Acute abdomen Anaemia Weight loss Extra-intestinal manifestations
312
Crohn's disease
Western populations Occurs at any age but peak onset in teens/twenties White 2-5x > non-white Higher incidence in Jewish population Smoking Whole of GI tract can be affected (mouth to anus) ‘Skip lesions’ Transmural inflammation Fissure/ sinus/fistula formation Non-caseating granulomas (organised collection of activated macrophages)
313
Extra-intestinal features of Crohn's
Arthritis Uveitis Stomatitis/cheilitis Skin lesions: - Pyoderma gangrenosum - Erythema multiforme - Erythema nodosum
314
Ulcerative colitis
Slightly more common than Crohn’s Whites > non-whites Peak 20-25 years but can affect any age Involves rectum and colon in contiguous fashion. May see mild ‘backwash ileitis’ ('reflux' of toxins - only when whole colon involved) and appendiceal involvement but small bowel and proximal GI tract not affected. Inflammation confined to mucosa Bowel wall normal thickness Shallow ulcers
315
Ulcerative colitis complications
Severe haemorrhage Toxic megacolon Adenocarcinoma (20-30 x risk) (adenocarcinoma risk also in Crohn's but less significant)
316
Ulcerative colitis extra-intestinal features
Arthritis Myositis Uveitis/iritis Erythema nodosum, pyoderma gangrenosum Primary Sclerosing Cholangitis (5.5% in pancolitis) --> increased risk of cholangiocarcinoma UC and PSC screened for when the other is present
317
Crypt abscesses
marker of active inflammation in Crohn's and Ulcerative colitis caused by accumulation of neutrophils in lumen
318
Lower GI tumours
Non-neoplastic polyps Neoplastic epithelial lesions - Adenoma - Adenocarcinoma (arise from adenomas) - Neuro-endocrine Tumours Mesenchymal lesions - Lipoma - Leiomyoma etc Lymphoma Stromal tumours
319
Colon and rectum tumours
Polyps - Non-neoplastic: Hyperplastic polyps and Sessile Serrated Lesions Inflammatory (“pseudo-polyps”) Hamartomatous (Juvenile, Peutz Jeghers) Polyps – Neoplastic (adenomas) : Tubular adenoma (completely flat) Tubulovillous adenoma Villous adenoma (have finger-like projections)
320
Sessile serrated lesions
subset of hyperplastic polyps (excessive epithelial proliferation) Hyperplastic polyp with architectural abnormalities (horizontal crypts at the base rather than vertical) May show dysplasia as well
321
Adenomas
Excess epithelial proliferation + dysplasia 20-30% prevalence before age 40 40-50% prev. after age 60 Types Tubular Villous Tubulovillous
322
Prognostic factors for polyps (cancer risk factors)
Size (bigger = worse) Proportion of villous component (more = worse) Degree of dysplasia (high grade worse than low grade)
323
Adenomas clinical features
Usually none Bleeding/anaemia
324
Familial syndromes with lower GI polyps
(Peutz Jeghers) - hamartomatous (usually no increased cancer risk) Familial adenomatous polyposis Gardner’s Hereditary non polyposis (<10 polyps) colon cancer
325
Family adenomatous polyposis (FAP)
Autosomal dominant - average onset is 25 years old Adenomatous polyps, mostly colorectal Minimum 100 polyps, average ~1,000 polyps chromosome 5q21, APC tumour suppressor gene virtually 100% will develop cancer within 10 to 15 years 5% periampullary (duodenum) Ca
326
Gardner's syndrome
subset of FAP FAP plus extra-intestinal manifestations e.g: osteomas desmoid tumors
327
Hereditary non-polyposis colorectal cancer (HNPCC)
= lynch syndrome Autosomal dominant May have polyps 3-5% of all colorectal cancers At least 1 of 4 DNA mismatch repair genes involved Numerous DNA replication errors Onset of colorectal cancer at an early age High frequency of carcinomas proximal to splenic flexure Poorly differentiated and mucinous carcinoma more frequent Multiple synchronous cancers Presence of extracolonic cancers (endometrium, prostate, breast, stomach)
328
Colorectal carcinoma
98% are adenocarcinoma Age: 60-79 years If < 50yrs consider familial syndrome Western population aetiology: Familial Diet (low fibre, high fat etc) Lack of exercise Obesity Predisposing conditions: - Chronic Inflammatory bowel disease - Adenomas
329
Symptoms of colorectal carcinoma
Change of bowel habit Bleeding Anaemia Weight loss Pain
330
Cells of the liver
Hepatocytes Bile ducts Blood vessels Endothelial cells Kupffer cells Stellate cells
331
Stellate cell activation
stellate cells lie between the hepatic sinusoid endothelial cells and the hepatocytes they store vitamin A when they become activated they become myofibroblasts (leading to collagen secretion and cirrhosis in chronic liver disease and also leads to decreased blood supply to hepatocytes due to barrier created between them and sinusoid)
332
Cirrhosis definition
1. whole liver involved 2. fibrosis 3. nodules of regenerating hepatocytes 4. distortion of liver vascular architecture: intra- and extra- hepatic (e.g. gastro-oesophageal) shunting of blood
333
Cirrhosis classification
a) according to nodule size: micronodular or macronodular b) according to aetiology: 1) alcohol (tend to cause micronodular) / insulin resistance 2) viral hepatitis (usually macronodular) etc.
334
Complications of cirrhosis
1. Portal hypertension 2. Hepatic encephalopathy (toxins into systemic circulation instead of being taken up and broken down by kupffer cells) 3. Liver cell cancer
335
Acute hepatitis
Aetiology: viruses and drugs Histology: spotty necrosis (little foci of hepatocyte damage)
336
Chronic hepatitis
> 6 months Aetiology: viral (B,C,D), drugs, auto-immune inflammation severity = grade fibrosis severity = stage histology: portal inflammation, interface hepatitis (piecemeal necrosis), lobular inflammation (spotty necrosis), fibrosis (bridging between portal tracts and central vein = intrahepatic shunting)
337
Alcohol related liver disease
1) fatty liver (reversible) 2) alcohol-related hepatitis 3) cirrhosis (potentially reversible) (somewhat sequential)
338
Alcohol-related hepatitis
Ballooning ( +/- Mallory Denk Bodies = cytoskeleton clumps) Fat Pericellular fibrosis Mainly seen in Zone 3 (most metabolically active cells so where most alcohol is converted to acetaldehyde which is the toxic compound causing damage)
339
NAFLD and NASH
Now MAFLD (metabolic associated fatty liver disease) and MASH (metabolic associated steatohepatitis) Histologically looks like alcoholic liver disease Due to insulin resistance associated with raised BMI and diabetes Becoming recognised as one of the commonest causes of liver disease, world-wide
340
Primary biliary cholangitis (PBC)
Previously primary biliary cirrhosis. Autoimmune F> M Bile duct loss associated with chronic inflammation (with granulomas) Diagnostic test is detection of anti-mitochondrial antibodies associated with raised levels of IgM in blood
341
Primary sclerosing cholangitis (PSC)
M > F Periductal bile duct fibrosis leading to loss Associated with ulcerative colitis Increased risk of cholangiocarcinoma Diagnostic test is bile duct imaging
342
Haemochromatosis
Genetically determined increased gut iron absorption (2mg instead of 1mg) manifests earlier in men because iron balance is more borderline in women Gene on chromosome 6 (HFe) - common mutation in celtic population Parenchymal damage to organs secondary to iron deposition (bronzed diabetes) causes liver cirrhosis (accumulation or iron in hepatocytes), cardiomyopathy, pancreatitis etc.
343
Haemosiderosis
accumulation of iron in macrophages (better at dealing with excess iron than hepatocytes) caused by blood transfusion
344
Wilson's disease
Accumulation of copper due to failure of excretion by hepatocytes into the bile Assessed by biopsy or biochemistry Genes on chromosome 13 Accumulates in the liver and CNS (hepato-lenticular degeneration - choreiform movements) including Kayser-Fleishcer rings (deposition in cornea)
345
Autoimmune hepatitis
F>M Active chronic hepatitis with plasma cells Anti-smooth muscle actin or anti-liver kidney microsomal antibodies in the serum Responds to steroids
346
Alpha-one antitrypsin deficiency
Failure to secrete alpha-one antitrypsin Intra-cytoplasmic inclusions due to misfolded protein Hepatitis and cirrhosis
347
Drug related liver injury
“any kind of liver disease can be caused by a drug” ie. hepatocellular and / or cholestatic 10% of drug reactions involve the liver May be dose-related or idiosyncratic Paracetamol toxicity: damage in zone 3 (most metabolically active cells)
348
Hepatic granulomas
Specific causes: PBC drugs General causes TB Sarcoid etc
349
Benign liver tumours
1) liver cell adenoma 2) bile duct adenoma 3) haemangioma (sharply circumscribed)
350
Malignant liver tumours
1. secondary tumours (metastasis through portal circulation) 2. primary tumours: hepatocellular carcinoma hepatoblastoma cholangiocarcinoma haemangiosarcoma
351
Hepatocellular carcinomas
Usually associated with cirrhosis especially in the West. Raised alpha-fetoprotein Poor prognosis
352
Cholangiocarcinomas
Associated with: PSC Worm infections Cirrhosis Can arise from: intrahepatic ducts extrahepatic ducts (including gall bladder)
353
Atherosclerosis
characterised by atheromatous deposits in and fibrosis of the inner layer of the arteries can cause occlusion and protrude through lumen
354
RFs for atherosclerosis
- age (progressive between 40->60 incidence x5) - sex (M>F, premenopausal women protected, postmenopausal risk increases, older age F>M) genetics (family history, familial hypercholesterolaemia, genetic polymorphisms) - hyperlipidaemia (modifiable) - hypertension (motifiable, alone increases risk of IHD by 60%) - smoking (prolonged doubles death rate from IHD, stopping reduces risk considerably) - diabetes mellitus (increases hyperchol and atherosclerosis) risk factors have multiplicative effect other RFs: inflammation, metabolic syndrome, lipoprotein, haemostasis (procoagulation), lack of exercise, stress, obesity
355
Atherosclerosis pathogenesis
chronic inflammatory and healing response of arterial wall to endothelial injury Lesion progression occurs through interaction of modified lipoproteins, monocyte-derived macrophages, and T lymphocytes with endothelial cells and smooth muscle cells of the arterial wall. 1. endothelial injury and dysfunction 2. LDL accumulation 3. Monocyte adhesion to endothelium 4. Monocyte migration into intima --> macrophages and foam cells 5. platelet adhesion 6. factor release and smooth muscle cell recruitment 7. wall thickening
356
Fatty streaks
earliest lesions lipid-filled foamy macrophages no flow disturbance in virtually all children relationship to plaques uncertain same sites as plaques
357
Atherosclerotic plaques
patchy - cause local flow disturbances only involve portion of wall rarely circumferential appear eccentric composed of: cells, lipid, matrix
358
Consequences of atheroma
stenosis: critical when demand>supply, occurs at approx 70% occlusion, causes stable angina, can lead to chronic IHD, acute plaque rupture can occur acute plaque change: rupture, erosion, haemorrhage (rupture and erosion expose prothrombogenic components)
359
Vulnerable plaques
adrenalin increases blood pressure and causes vasoconstriction increases physical stress on plaque hence emotional stress increases risk of sudden death circadian periodicity to sudden death (6am-noon) (thin fibrous cap and large lipid core: more likely to rupture)
360
IHD
group of conditions resulting from MI imbalance of supply to demand for oxygenated blood less nutrients and less waste removal less well tolerated than pure hypoxia gradual progression before symptoms Presentation: - angina pectoris - MI - chronic IHD with heart failure - sudden cardiac death
361
IHD pathogenesis
insufficient coronary perfusion relative to myocardial demand due to chronic progressive atherosclerotic narrowing of epicardial coronary arteries and variable degrees of superimposed plaque change, thrombosis, vasospasm 75% stenosis or more needed to cause symptoms precipitated by exercise, vasodilation cannot compensate above this level of stenosis 90% stenosis can lead to pain at rest
362
ACS
stable plaque becomes unstable due to rupture, erosion, haemorrhage can lead to superimposed thrombus which increases occlusion
363
Angina pectoris
transient ischaemia not producing myocyte necrosis includes: stable, Prinzmetal, Unstable stable comes on with exertion, relieved by rest no plaque disruption Prinzmetal is uncommon and is due to artery spasm
364
Unstable angina
more frequent longer onset with less exertion or at rest disruption of plaque superimposed thrombus possible embolisation or vasospasm warning of impending infarction
365
MI
death of cardiac muscle due to prolonged ischaemia = necrosis incidence increases with age M>F IHD most common cause of death in postmenopausal women
366
MI pathogenesis
(artery occlusion) 1. sudden change to plaque 2. platelet aggregation 3. vasospasm 4. coagulation 5. thrombus evolves myocardial response: blood supply compromised --> ichaemia --> loss of contractility within 60 seconds (heart failure can precede myocyte death) potentially reversible but irreversible after 20-30 minutes
367
Reperfusion injury
clinical importance uncertain due to oxidative stress, calcium overload and inflammation mitochondrial swelling and apoptosis leukocyte aggregation and occlusion of microvasculature arrhythmias common biochem abnormalities last days-weeks thought to cause stunned myocardium - reversible cardiac failure lasting several days
368
MI complications
contractile dysfunction arrhythmia (myocardial irritability and conduction disturbance) myocardial rupture (LV free wall most common, septum less common, papillary muscle least common, at mean 4-5 days) pericarditis (dressler syndrome) RV infarction Infarct extension (necrosis spread) Infarct expansion (necrotic muscle stretches) mural thrombus
369
Chronic IHD
progressive HF due to ishaemic myocardial damage may not be prior infarction can arise with severe obstructive CAD enlarged heavy heart, hypertrophied, dilated LV atherosclerosis maybe mural thrombi microscopic fibrosis
370
sudden cardiac death
unexpected death from cardiac causes in individuals without symptomatic heart disease or early (1hr) after symptoms onset usually due to lethal arrhythmia (sustained AF or asystole) usually on background of IHD ischaemia induced electrical instability marked atherosclerosis
371
Bone tumours
* Very rare * can be benign or malignant * malignant tumours 60x less common than lung cancer * primary malignant bone tumours most common in children and young adults * Site predilection - around knee most common * Different tumours have different site and age predilection * Clinical information and ‘team’ approach to diagnosis essential
372
Bone tumour diagnosis
Clinical presentation: * pain, swelling, deformity, fracture History: * age, site, duration, ?hx of trauma * ?multiple lesions, ?associated disease X ray: * Evaluate site, size, margin * ?solitary or multiple, ?soft tissue extension * ?associated disease or fracture * Optimal treatment is early referral to specialist centre Biopsy: * Needle biopsy preferred option * Performed by radiologist usually with Jamshidi needle * +/- US or CT guidance * Open biopsy for sclerotic or inaccessible lesions * Imprint (cytology) preparations are very useful
373
Bone tumour-like conditions
* Fibrous dysplasia * Metaphyseal fibrous cortical defect/non-ossifying fibroma * Reparative giant cell granuloma * Ossifying fibroma * Simple bone cyst
374
Fibrous dysplasia
* F>M mono-ostotic > polyostotic * Age: 1st 3 decades * Site: any bone, ribs, prox femur commonest * Xray: ‘soap bubble’ osteolysis * polyostotic disease can be associated with endocrine problems and rough border café au lait spots on skin (McCune Albright syndrome) * <1% malignant transformation * Somatic mutation in guanine-nucleotide binding protein (G-protein). (GNAS mutation chr 20 q13) * histology: trabecular bone (chinese letters) * complications: shepherd's crook deformity
375
Benign bone tumours
* Cartilaginous differentiation * Osteochondroma (age 10-20, M:F 2:1, common sites = at ends of long bones) * Enchondroma (age 10-40, M:F equal, common sites = hands and fingers, popcorn calcification on x-ray) * Chondroblastoma * Bone forming * Osteoid osteoma * Osteoblastoma * Osteoma
376
Giant cell bone tumours
borderline malignancy Site: epiphysis with metaphyseal extension Age: 20-40 y F>M X-ray: Lytic Histo: osteoclasts on a background of spindle/ovoid cells Locally aggressive, may recur, can metastasise Mx: excision with narrow margins
377
Commonest malignant bone tumours
= metastases (unusual below knee/elbow) Adults: * Breast * Prostate * Lung * Kidney * Thyroid Children: * Neuroblastoma * Wilm’s tumour * Osteosarcoma * Ewings * Rhabdomyosarcoma
378
Malignant bone tumours
Osteosarcoma Chondrosarcoma Ewing’s sarcoma/PNET (primitive peripheral neuroectodermal tumour)
379
Osteosarcoma
Commonest primary bone sarcoma Age: peak in adolescence (75% patients are <20y) M:F 2:1 Site: 60% occur around the knee X-ray: usually metaphyseal, lytic, permeative, elevated periosteum(Codman’s Triangle) Histo: malignant mesenchymal cells +/- bone and cartilage formation Prognosis: poor- 60% 5 year survival. Treatment is usually chemo and limb salvage surgery
380
Osteosarcoma classification
1. According to site within bone:- i.e. intramedullary, intracortical, surface 2.Degree of differentiation:- i.e. high, intermediate or low grade 3. Multicentricity:- i.e. synchronous or metachronous 4.Primary or secondary.
381
Chondrosarcoma
Malignant cartilage producing tumour Age: 40y and over M:F 5:4 Site: pelvis, axial skeleton, prox femur, prox tibia X-ray: lytic with fluffy calcification Histo: malignant chondrocytes +/- chondroid matrix may dedifferentiate to high grade sarcoma Prognosis: 70% 5y survival (depends on grade & size)
382
Chondrosarcoma classification
1. According to site intramedullary, juxtacortical 2. Histologically conventional (myxoid or hyaline), clear cell, dedifferentiated, mesenchymal
383
Ewing's sarcoma/PPNET
Highly malignant small round cell tumour Age: usually < 20y (80%) M:F 4:3 Site: diaphysis/metaphysis of long bones, pelvis X-ray: onion skinning of periosteum, lytic +/- sclerosis Histo: sheets of small round cells, MIC2 stain positive Prognosis : - 75% 5y survival 50% longterm Specific chromosome translocation 11:22 (EWS/Fli1)
384
Soft tissue tumours
Defined as mesenchymal proliferations which occur in the extraskeletal, non-epithelial tissues of the body - excluding meninges and lymphoreticular system Site: Anywhere. Majority occur in large muscles of extremities, chest wall, mediastinum, retroperitoneum Age: Any age. Majority older patients 15% < 15yrs 50% > 55yrs Sex: M>F overall, but sex and age varies between histological types Race: No proven racial variation Ewing’s and clear cell sarcoma rare in Afrocaribbean population
385
Soft tissue tumours aetiology
- uncertain Factors Include: - Genetic Predisposition - Chemical carcinogens - Physical ( asbestos, foreign body ) - Viruses - Immunodeficiency
386
Types of soft tissue tumours
liposarcoma/myxoid tumours spindle cell tumours pleomorphic sarcoma synovial sarcoma
387
Soft tissue tumours diagnosis
Immunohistochemistry EM Cytogenetics (conventional & interphase) FISH M-FISH SKY CGH PCR RT-PCR
388
Soft tissue tumours prognostic factors
GOOD BAD Size <5cm >5cm Depth superficial to deep deep fascia to deep fascia Histological grade low high Excision margin clear involved Vascular invasion absent present Ploidy diploid aneuploid/ hyperdiploid Proliferation Index low high Tu. Supressor gene present absent Tu. Promoter gene absent present
389
Soft tissue tumour staging
Stage 0 3 good prognostic signs 1 2 good 1 bad 2 1 good 2+ bad 3 3+ bad 4 metastases, regional or distant
390
Pituitary gland structure
anterior: epithelial cells (derived from oral cavity), with blood supply from pituitary portal system releases hormones under stimulation from hypothalamus posterior: neuroendocrine cells with blood supply from nerves from hypothalamus
391
Pituitary diseases
Hyperpituitarism: excess secretion of trophic hormones (usually due to functional adenoma) - classified on basis of hormones produced (most common are prolactin) Hypopituitarism: deficiency of trophic hormones Local mass effects
392
Pituitary adenomas symptoms
Prolactinomas: - amenorrhoea, galactorrhoea, loss of libido, infertility - usually diagnosed earlier in females of reproductive age Growth hormone adenomas: - in prepubertal children: gigantism - in adults: acromegaly - diabetes mellitus, muscle weakness, hypertension, congestive cardiac failure Corticotroph cell adenomas: - Cushing's syndrome
393
Hypopituitarism
most are caused by: non-secretory pituitary adenomas Ischaemic necrosis (most commonly post-partum) - can also be causes by DIC, sickle cell anaemia, elevated ICP, shock Ablation of pituitary by surgery or irradiation
394
Hypopituitarism symptoms
Children: growth failure (pituitary dwarfism) Gonadotrophin deficiency: amenorrhea and infertility in women, decreased libido and impotence in mean TSH & ACTH deficiency: hypothyroidism and hypoadrenalism Prolactin deficiency: failure of lactation post-partum
395
Posterior pituitary syndromes
(mainly involves ADH) Diabetes insipidus (too little ADH) SIADH (due to brain trauma usually, will present with profound hyponatraemia)
396
Local mass effects of pituitary tumours
compression of optic chiasm leading to bitemporal hemianopia signs and smptoms of elevated ICP (headaches and papilloedema) Obstructive hydrocephalus (late stage, compression of brain stem and herniation through foramen magnum)
397
Thyroid gland histology
(2 lobes connected by isthmus) colloid-filled follicles with interstitial tissue between them follicles lined by epithelial cells scattered cells between follicles: parafollicular cells/C cells (synthesis calcitonin)
398
Non-toxic thyroid goitre
= enlargement of thyroid common if impaired synthesis of thyroid hormone (most often due to iodine deficiency) commonly seen in puberty in females may be caused by ingestion of substances that interfere with thyroid hormone synthesis (eg brassicas) or hereditary enzyme defects (thyroglobulin) may progress to multinodular goitre which can be large in mass and cause airway/oesophageal obstruction
399
Papillary thyroid carcinoma
may occur at any age may have papillary architecture diagnosis based on nuclear features: - optically clear nuclei - intranuclear inclusions May have psammoma bodies (little foci of calcification) nonfunctional --> present as painless mass in neck, may present with metastasis in cervical lymph nodes 10 year survival 90% with appropriate treatment
400
Follicular thyroid carcinoma
peak incidence in middle age follicular morphology (look similar to normal tissue) may be well demarcated with minimal invasion or clearly infiltrative usually metastasise via bloodstream to lungs, bone and liver
401
anaplastic thyroid carcinoma
occur in elderly patients very aggressive metastases common most cause death within one year due to local invasion (may just be very aggressive follicular carcinomas)
402
Parathyroid glands
derive from developing pharyngeal pouches usually 4 of them usually to upper and lower poles of thyroid but may be in thymus or anterior mediastinum activity controlled by level of free calcium in blood --> decreased calcium stimulates release of PTH
403
PTH actions
- activates osteoclasts - increases renal tubular reabsorption of calcium - increases conversion of vitamin D to its active form - increases urinary phosphate excretion - increases intestinal calcium absorption
404
Hyperparathyroidism
most commonly due to solitary benign adenoma less commonly due to hyperplasia of all 4 glands (sporadic or MEN1) very rarely due to carcinoma increased level of serum ionised calcium (usually incidental finding)
405
Primary hyperparathyroidism manifestations
Osteitis fibrosa cystica (bone resorption with cortex thinning and cyst formation) Renal stones and obstructive uropathy GI disturbances; constipation, pancreatitis, gallstones CNS alterations; depression, lethargy, fits neuromuscular abnormalities; weakness polyuria and polydipsia
406
Secondary hyperparathyroidism
caused by any condition associated with chronic depression of serum calcium renal failure is most common cause parathyroid glands are enlarged (may be asymmetrical) leads to bone changes as with primary disease
407
Hypoparathyoidism
causes: - surgical ablation - congenital absence - autoimmune clinical manifestations: - neuromuscular irritability (tingling, muscle spasms, tetany) - cardiac arrhythmias - fits - cataracts
408
Adrenal gland
Cortex surrounds medulla cortex is made up of epithelial cells medulla made up of neural cells and secretes noradrenaline and adrenaline
409
3 zones of adrenal cortex
outer: zona glomerulosa, secretes aldosterone middle: zona fasciculata, secretes glucocorticoids inner: zona reticularis, secretes androgens and glucocorticoids
410
Causes of primary adrenal insufficiency
Acute: - sudden withdrawal of steroids - haemorrhage (neonates) - sepsis with DIC Chronic: - autoimmune (Addison's) - TB - HIV - metastatic tumour (esp lung and breast) - rarely amyloid, fungal infections, haemochromatosis, sarcoidosis
411
Function of bone
Mechanical: support and site for muscle attachment Protective: vital organs and bone marrow Metabolic: calcium reserve
412
Bone composition
Inorganic (65%): - calcium hydroxyapatite - storehouse for 99% of Ca in body - 85% of phosphorous and 65% of Na and Mg Organic (35%): - bone cells and protein matrix
413
Bone geography
Outside to in: periosteum, cortex, medulla Diaphysis (longer) and Epiphysis separated by metaphysis
414
Types of bone
Cortical: - long bones - 80% of skeleton - appendicular - 80-90% calcified - mainly mechanical and protective Cancellous: - vertebrae & pelvis - 20% of skeleton - axial - 15-25% calcified - mainly metabolic - large surface
415
Cortical bone microanatomy
Haversian canals going up and down surround haversian canals: concentric lamallae in between those units: interstitial lamallae surrounding (outside): circumferential lamallae deeper inside: trabecular lamallae
416
Cancellous bone microanatomy
trabecular lamallae and haematopoietic cells on H&E staining
417
Bone cells
Osteoblasts: build bone by laying down osteoid (smaller cells, single nucleus) Osteoclasts: multinucleate cells of macrophage family resorb or chew bone Osteocytes: osteoblast-like cells which sit in lacunae (small, single nucleus)
418
Osteoprotegrin
Blocks RANK-RANK ligand interaction to prevent osteoclast differentiation for precursor
419
Metabolic bone disease
= disordered bone turnover due to imbalance of chemicals in body overall effect: osteopenia --> fractures with little trauma
420
3 main categories of bone disease
1. Non-endocrine (eg. age-related osteoporosis) 2. related to endocrine abnormality (Vit D, PTH) 3. Disuse osteopenia
421
Histology for metabolic bone disease
bone biopsy from iliac crest; processed in un-decalcified form for histomorphometry 'static' parameters: - cortical thickness and porosity - trabecular bone volume - thickness, number & separation of trabeculae bone mineralisation is studied using osteoid parameters 'histodynamic parameters' are obtained from fluorescent tetracycline labelling
422
Osteoporosis
90% of cases due to insufficient Ca intake and post-menopausal oestrogen deficiency (primary - age & post-menopause, secondary - drugs, systemic disease) high turnover = increased bone resorption low turnover = decreased bone formation fracture pathogenesis: low initial bone mass or accelerated bone loss can reduced bone mass below fracture threshold
423
Risk factors for Osteoporosis
advanced age female sex smoking excess alcohol early menopause long-term immobility low BMI poor diet (low vit D and Ca) malabsorption thyroid disease low testosterone chronic renal disease steroids
424
Typical osteoporosis presentation
back pain + wrist (Colles'), hip (NOF, intertrochanteric) or pelvis fracture (may be asymptomatic) compression fractures can also occur at T11-12 level
425
Ix for osteoporosis
Lab: - serum calcium, phosphorous, alk phos - urinary calcium - collagen breakdown products Imaging Bone densitometry: - T score 1-2.5 = osteopenia - T score >2.5 = osteoporosis
426
Parathyroid abnormalities
4 organs affected which control Ca metabolism: Parathyroid glands bones kidneys proximal small intestine
427
Osteomalacia
= defective bone mineralisation 2 types: deficiency of Vit d or phosphorous sequelae: bone pain/tenderness fracture (horizontal in looser's zone) proximal weakness bone deformity (eg. bowing in rickets)
428
Hyperparathyroidism
- increased Ca and PO4 excretion in urine - hypercalcaemia - hypophosphataemia - skeletal changes of osteitis fibrosa cystica
429
Causes of hyperparathyroidism
Primary: - parathyroid adenoma (85-90%) - chief cell hyperplasia Secondary: - chronic renal deficiency - vit d deficiency - malabsorption
430
Hyperparathyroidism symptoms
stones (renal), bones (osteitis fibrosa cystica), abdominal groans (constipation, pancreatitis), psychic moans (psychosis, depression)
431
Renal osteodystrophy
= all skeletal changes of chronic renal disease: - osteitis fibrosa cystica - osteomalacia - osteosclerosis - growth retardation - osteoporosis
432
Paget's disease
= disorder of bone turnover 3 phases: 1. osteolytic 2. osteolytic-osteosclerotic 3. quiescent osteosclerotic onset>40y M=F
433
Paget's disease aetiology
unknown autosomal pattern of inheritance with incomplete penetrance parvomyxovirus type particles sites affected: mainly pelvis and skull
434
Paget's disease clinical presentation
pain microfractures nerve compression skull changes (may put medulla at risk) haemodynamic changes (cardiac failure) development of sarcoma in area of involvement (1%)
435
Types of fractures
simple, compound, greenstick (children), comminuted (trauma), impacted
436
Fracture repair stages
1. organisation of haematoma at fracture site (pro-callus) 2. formation of fibrocartilaginous callus 3. Mineralisation callus 4. Remodelling of bone along weight-bearing lines
437
Factors influencing fracture healing
type presence of infection pre-existing systemic condition (tumour, metabolic disorder, drugs, vitamin deficiency)
438
Osteomyelitis
malaise, fever, chills, leucocytosis pain, swelling, redness 60% positive blood cultures XR: mixed picture, eventually lytic almost always bacterial routes: haematogenous, direct extension, traumatic (incl. surgery)
439
Causative organisms of osteomyelitis
mainly staph aureus also: E. coli, klebsiella, salmonella, psuedomonas, haemphilus influenzae, group b strep
440
Osteomyelitis X-ray changes
10 days post-onset mottled rarefaction and lifting of periosteum Involucrum: irreg sub-periosteal new bone formation (>1week) Irregular lytic destruction (10-14 days) sequestra: necrotic cortex areas become detached (3-6 weeks)
441
TB affects on bone (osteomyelitis)
spinal disease may result in psoas abscess and severe skeletal deformity (Pott's disease) systemic amyloidosis
442
Syphilis osteomyelitis
(rare) congenital skeletal lesions: - osteochondritis - osteoperiostitis - diaphyseal osteomyelitis acquired (late) skeletal lesions: - non-gummatous periostitis - gummatous inflammation of bone and joints - neuropathic joints - neuropathic shaft fractures
443
Lyme disease
inflammatory arthropathy from tick bite organism: borrelia burgdorferi Tick species: Ixodes dammini skin rash: erythema chronicum migrans Musculoskeletal effects seen in early disseminated phase and late/persistent phase dominated by arthritis Mx: prevention & vaccination, Abx for proven disease, clinical diagnosis
444
Osteoarthritis
Primary: age-related Secondary: any age, previously damaged or congenitally abnormal joint aetiology unknown but results in: cartilage degeneration, fissuring, abnormal matrix calcification, osteophytes main sites: vertebrae, hips, knees
445
OA XR features
loss of joint space subchondral sclerosis cystic lesions osteophytes
446
Rheumatoid arthritis
severe chronic relapsing synovitis unpredictable course F:M = 3:1 Age 30-40y aetiology: most likely autoimmune, some genetic predisposition, association with HLA DR4 & DR1 80% RF +ve (RF forms immunocomplexes with IgG)
447
RA clinical features
mild anaemia raised ESR RF +ve +/- rheumatoid nodules multisystem disease sites: small joints, hands, feet, sparing of DIPJ wrists, elbows, ankles, knees
448
RA characteristic deformities
radial deviation of wrist ulnar deviation of fingers 'swan neck' and 'boutonniere' deformity of fingers 'Z' shaped thumb
449
RA XR features
soft tissue swelling joint space narrowing erosions subchondral cysts
450
RA histology
Proliferative synovitis with: 1. thickening of synovial membranes 2. hyperplasia of surface synoviocytes 3. intense inflammatory cell infiltrate 4. fibrin deposition and necrosis Pannus formation with exuberant inflamed synovium overlying the articular surface